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Abstract
Type III secretion is a tightly controlled virulence mechanism utilized by many gram negative bacteria to colonize their
eukaryotic hosts. To infect their host, human pathogenic Yersinia spp. translocate protein toxins into the host cell
cytosol through a preassembled Ysc-Yop type III secretion device. Several of the Ysc-Yop components are known for
their roles in controlling substrate secretion and translocation. Particularly important in this role is the YopN and TyeA
heterodimer. In this study, we confirm that Y. pseudotuberculosis naturally produce a 42 kDa YopN-TyeA hybrid
protein as a result of a +1 frame shift near the 3 prime of yopN mRNA, as has been previously reported for the
closely related Y. pestis. To assess the biological role of this YopN-TyeA hybrid in T3SS by Y. pseudotuberculosis,
we used in cis site-directed mutagenesis to engineer bacteria to either produce predominately the YopN-TyeA hybrid
by introducing +1 frame shifts to yopN after codon 278 or 287, or to produce only singular YopN and TyeA
polypeptides by introducing yopN sequence from Y. enterocolitica, which is known not to produce the hybrid.
Significantly, the engineered 42 kDa YopN-TyeA fusions were abundantly produced, stable, and were efficiently
secreted by bacteria in vitro. Moreover, these bacteria could all maintain functionally competent needle structures
and controlled Yops secretion in vitro. In the presence of host cells however, bacteria producing the most genetically
altered hybrids (+1 frameshift after 278 codon) had diminished control of polarized Yop translocation. This
corresponded to significant attenuation in competitive survival assays in orally infected mice, although not at all to the
same extent as Yersinia lacking both YopN and TyeA proteins. Based on these studies with engineered
polypeptides, most likely a naturally occurring YopN-TyeA hybrid protein has the potential to influence T3S control
and activity when produced during Yersinia-host cell contact.
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Introduction
Invertebrate and vertebrate hosts are potentially subject to a
myriad of bacterial infections. Scores of these infectious agents
are Gram-negative bacterial pathogens that colonize their
eukaryotic hosts through a virulence strategy that involves
having a type III secretion system (T3SS) as the centrepiece
[1,2]. Similar systems also function in the biosynthesis of the
flagellum motility organelle and in establishing mutualistic
interactions between bacteria and their eukaryotic hosts. At
least in pathogenic bacteria, target cell contact triggers a pre-
assembled needle-like T3SS consisting of ~25 proteins
spanning the bacterial envelope to become competent for
delivery of newly synthesized effector toxins direct from the
bacterial interior into the host cell cytosol in a one- or two-step
process that presumably involves effector transit through a
translocon pore formed in the host cell membrane [3]. At least
three types of protein substrates are known to be secreted by a
T3SS [4]; early substrates are those that contribute to the final
phase of polymerizing the external needle appendage, middle
substrates are pore-forming translocator proteins that bridge
the gap between the protruding needle and host cell surface,
thereby facilitating the passage of late substrates into the host
cell interior. These late substrates are the effector toxins that
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harbour diverse enzymatic activities to manipulate host-cell
signalization. This can affect many aspects of cell and host
physiology – for instance immune system responsiveness, to
promote bacterial survival in the host and host-to-host
transmission [5].
This functional demarcation of substrate classes implies that
their production and subsequent secretion is needed only at
discrete phases during T3S activity. To ensure this concise
temporal and spatial control, multiple layers of regulatory
control are needed [1,6-10]. Common to all T3SSs appears to
be a substrate switching mechanism which, following assembly
of the needle extension, triggers a change in substrate
secretion from early needle components to the middle
translocators and late effectors. This notion is based on a
plethora of studies that have dissected aspects of the complex
crosstalk between YscU-like, YscP-like and YscI-like protein
families that are highly conserved in both flagella and non-
flagella T3SSs [11-24].
It is also anticipated that a secretion order may exist among
the middle and late secretion substrates. This is based on the
assertion that a translocon pore should form in the host cell
plasma membrane prior to the secretion of the translocated
toxins. Indeed, accumulating genetic studies are providing
evidence that in some bacteria middle substrates are prioritized
for secretion over late substrates. A growing heterogeneous
family of proteins headlined by InvE of S. enterica Typhimurium
are being reported for their roles in ensuring translocator
secretion before effector secretion in their respective bacteria.
InvE directly recognizes translocator-chaperone complexes
that may prioritize their secretion [25,26]. Alternatively, the C-
terminus of SepL may specifically bind effector substrates to
stall their T3S from enteropathogenic Escherichia coli [27-29]
or MxiC may bind the system ATPase creating a blockade that
similarly inhibits effector secretion by Shigella flexneri
[19,30,31]. No matter how it is achieved, these studies identify
intrinsic mechanisms for orchestrating hierarchical secretion
among the T3S translocator and effector substrates. A
Conserved Domain Database (CDD) [32] search revealed a
distinct HrpJ-like domain (denoted pfam07201) architecture in
all of them (Figure 1A), although only a modest amount of
sequence identity is shared between them [33]. For example,
amino acid identity within the HrpJ-like domain is highest
(36.86%) between InvE and MxiC, but then sharply drops away
for the others (Figure 1B).
InvE-family homologues were also reported within the
plasmid encoded Ysc-Yop T3SS carried by the infamous
Yersinia pestis, the etiological agent of plague, and the less
aggressive foodborne enteropathogens Y. enterocolitica and Y.
pseudotuberculosis. Intriguingly, this homology was partitioned
over two proteins; YopN with a HrpJ-like domain displayed
moderate identity to the N-terminus and TyeA followed with
modest identity over the C-terminus of each InvE-family
member (Figure 1A) [33]. The region of YopN containing the
HrpJ-like domain was most identical at the amino acid level to
HrpJ (21.46%) (Figure 1B), while TyeA amino acid sequence
most closely resembled the C-terminal region of SepL
(25.68%) (Figure 1C). The YopN and TyeA proteins do function
as a 42kDa YopN-TyeA complex to control Yop substrate
secretion [34-36]. Moreover, YopN function is required for the
polarized translocation of T3S effectors into the host eukaryotic
cell [35,37,38]. Curiously, Y. pestis but not Y. enterocolitica
were observed to produce a singular 42 kDa YopN-TyeA hybrid
polypeptide; a consequence of a +1 frame shift that occurs
during translation of the 3’ -prime end of yopN mRNA. The
produced hybrid protein was competent for general T3S control
[39].
The mechanisms of Yop secretion control in Yersinia are
complex and require input from multiple contributing proteins
that function at different levels and in response to different
environmental cues [9,10,24,40-44]. This study had the goal to
further investigate the biological significance of the YopN-TyeA
hybrid given the documented roles played by YopN and TyeA
in Yop secretion control and their homology to the InvE-family.
To do so, we first confirmed the natural production and T3S of
the singular YopN-TyeA hybrid in Y. pseudotuberculosis. Next,
an in cis site directed mutagenesis approach generated Y.
pseudotuberculosis that either produced predominately the
YopN-TyeA hybrid by introducing +1 frame shifts to yopN after
codons 278 or 287, or produced only singular YopN and TyeA
polypeptides by introducing yopN sequence from Y.
enterocolitica. Like parental Yersinia, mutants that produced
solely the YopN-TyeA hybrid maintained T3SS assembly and
function in vitro and could also successfully establish systemic
colonization during competitive infections of mice. In light of
this functionality, a possible mechanism for regulating the
natural formation of the YopN-TyeA hybrid was explored.
Materials and Methods
Bacterial Strains, Plasmids and Growth Conditions
Strains and plasmids used in this study are listed in Table 1.
Routine bacterial culturing of E. coli and Y. pseudotuberculosis
was performed at 37°C and 26°C respectively, typically in Luria
Bertani (LB) broth. When examining protein expression and
secretion from Yersinia, strains were grown in brain heart
infusion (BHI) broth, both in minus calcium (BHI supplemented
with 5 mM EGTA and 20mM MgCl2 – T3S permissive medium)
and in plus calcium (2.5mM CaCl2 – T3S non-permissive
medium) conditions. In both cases, bacteria were grown in the
presence of 0.025% (v/v) Triton X-100. This treatment
detached Yops prone to associate to the bacterial surface,
thereby ensuring that our T3S analysis would include all Yops
secreted beyond the bacterial envelope [45]. When
appropriate, antibiotics at the following concentrations were
used to select for plasmid maintenance during culturing:
Carbinicillin (Cb) 100µg/ml, Chloramphenicol (Cm) 25µg/ml,
and Kanamycin (Km) 50µg/ml.
Mutant Construction
The various mutated yopN alleles were created by the
overlap PCR method using the various primer pairs listed in
Table S1. PCR fragments were cloned directly into pTZ57R/T
using the InsTAclone PCR cloning strategy (Thermo Scientific)
and each mutation confirmed by sequence analysis (Eurofins
MWG Operon, Ebersburg, Germany). Confirmed DNA
fragments were then lifted into the pDM4 suicide mutagenesis
Functional YopN-TyeA Chimeras
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Figure 1.  Domain architecture and sequence identity among the InvE-family of T3SS proteins.  YopN and TyeA from human
pathogen Yersinia sp. are two distinct polypeptides (A). In several other T3SSs, homologues to both YopN and TyeA exist as a
single polypeptide (for example, InvE, MxiC, SepL, SsaL and HrpJ). Numbers in parentheses indicate the full length (in amino acids)
of each protein. Other numbers indicate the bordering amino acids that demarcate YopN homology (blue shade) that is defined
Pfam as a HrpJ-like domain (pfam07201), TyeA homology (orange shade) or functionally relevant regions of YopN (various
coloured solid lines). The schematic illustration of YopN and TyeA homology domains within the InvE-family was derived from
comprehensive multiple sequence alignments coupled to a Conserved Domain Database (CDD) [32,33]. SS, secretion signal [80];
CBD, T3S chaperone (YscB-SycN heterodimer) binding domain [92]; CCD1 and CCD2, coiled-coil domain 1 and 2 [61]; TyeA BD,
TyeA binding domain [61,92]. Percent amino acid sequence identity between the InvE family of proteins was determined by
BLASTP analysis for the N-terminal HrpJ-like domain (equivalent to YopN) (B) and the C-terminal TyeA-like domain (C).
Representative sequences were retrieved from the NCIB genome database archived with the following GI reference numbers
shown in parentheses: Y. ps, Yersinia pseudotuberculosis YopN (48634); Y. ps TyeA (48635); S. ty, Salmonella enterica
Typhimurium InvE (16766203); S. fl, Shigella flexneri MxiC (12329090); E. co, Escherichia coli SepL (215267040); S. ty SsaL
(16419933); E. ch, Erwinia chrysanthemi HrpJ (28628125).
doi: 10.1371/journal.pone.0077767.g001
Functional YopN-TyeA Chimeras
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Table 1. Strains and plasmids used in this study.
Strains and
plasmids Relevant genotype or phenotype
Source or
reference
Strain   
E. coli
DH5 F
−, recA1, endA1, hsdR17, supE44, thi-1, gyrA96,
relA1
Vicky
Shingler
S17-1λpir recA, thi, pro, hsdR
-M+, SmR, <RP4:2-
Tc:Mu:Ku:Tn7>TpR [86]
Y. pseudotuberculosis
YPIII/pIB102 yadA::Tn5, KmR (wild type) [47]
YPIII/pIB75 pIB102, yscU in frame deletion of codons 25-329,KmR [87]
YPIII/
pIB75-26 pIB102, yscU and lcrQ double mutant, Km
R [45]
YPIII/pIB202 pIB102, yscF in frame deletion of codons 11-69,KmR [88]
YPIII/pIB619 pIB102, yopB and yopD full length deletion, KmR [89]
YPIII/pIB82 pIB102, near full length deletion of yopN, KmR [90]
YPIII/pIB801a pIB102, tyeA in frame deletion of codons 19-59,KmR This study
YPIII/
pIB8201a
pIB102, in frame double deletion of yopN and
tyeA, KmR This study
YPIII/pIB8214
pIB102, yopN allele with a missense mutation at
codon 286 (LysAAA→IleATA) to give a
YopNYps→Yen, KmR
This study
YPIII/pIB8205
pIB102, yopN allele with a +1 frameshift deletion
mutation (‘T’) after codon 278 to give a YopN278(F
+1)TyeA chimera, KmR
This study
YPIII/pIB8206
pIB102, yopN allele with a +1 frameshift deletion
mutation (‘T’) after codon 278 and the
conservative mutations at codons 283 and 284
(GlnCAG→CAA and ArgAGG→CGT) that partially
disrupts the presumed tyeA Shine-Dalgarno
sequence to give a YopN278(F+1), SDTyeA
chimera, KmR
This study
YPIII/pIB8210
pIB102, yopN allele with a +1 frameshift deletion
mutation (‘A’) after codon 287 to give a YopN287(F
+1)TyeA chimera, KmR
This study
YPIII/pIB8211
pIB102, yopN allele with a +1 frameshift deletion
mutation (‘A’) after codon 287 and the
conservative mutations at codons 283, 284 and
285 (SerTCA→TCC, GluGAG→GAA and
GlyGGT→GGC) that partially disrupts the presumed
tyeA Shine-Dalgarno sequence to give a
YopN287(F+1), SDTyeA chimera, KmR
This study
YPIII170/
pIB102
In cis polar mutation of YPK_3687 in the parental
background, CmR, KmR This study
YPIII170/
pIB8201a
In cis polar mutation of YPK_3687 in the yopN and
tyeA background, CmR, KmR This study
YPIII170/
pIB8214
In cis polar mutation of YPK_3687 in the
YopNYps→Yen-producing background, CmR, KmR
This study
YPIII170/
pIB8205
In cis polar mutation of YPK_3687 in the
YopN278(F+1)TyeA-producing background, CmR,
KmR
This study
Table 1 (continued).
Strains and
plasmids Relevant genotype or phenotype
Source or
reference
YPIII170/
pIB8206
In cis polar mutation of YPK_3687 in the
YopN278(F+1), SDTyeA-producing background,
CmR, KmR
This study
YPIII170/
pIB8210
In cis polar mutation of YPK_3687 in the
YopN287(F+1)TyeA-producing background, CmR,
KmR
This study
YPIII170/
pIB8211
In cis polar mutation of YPK_3687 in the
YopN287(F+1), SDTyeA-producing background,
CmR, KmR
This study
YPIII/pIB8215
pIB102, yopN allele with a conservative mutation
at codon 278 (PheTTT→PheTTC) to give a
YopNF278F, KmR
This study
YPIII/pIB8216
pIB102, yopN allele with a missense mutation at
codon 279 (TrpTGG→PheTTC) to give a
YopNW279F, KmR
This study
YPIII/pIB8217 pIB102, yopN allele with a deletion of codon 278to give a YopNΔ278F, KmR
This study
YPIII/pIB8218 pIB102, yopN allele with a deletion of codon 279to give a YopNΔ279W, KmR
This study
Y. enterocolitica
8081/
pYVe8081 clinical isolate, biotype 1b (serotype 0:8) [91]
Plasmid
pTZ57R/T PCR cloning and sequencing vector, CbR ThermoScientific
pMMB208 Expression vector, CmR [49]
pAA269 pMMB208 with full-length yopN and tyeA includingnative upstream SD sequences, CmR This study
pAA271 pMMB208 with chimeric yopN278(F+1), SDtyeAincluding native upstream SD sequences, CmR This study
pAA304 pMMB208 with full-length yopN and tyeA-flag®including native upstream SD sequences, CmR This study
pAA305
pMMB208 with full-length yopNYps→Yen and tyeA-
flag® including native upstream SD sequences,
CmR
This study
pAA306 pMMB208 with chimeric yopN278(F+1)tyeA-flag®including native upstream SD sequences, CmR This study
pAA307
pMMB208 with chimeric yopN278(F+1), SDtyeA-
flag® including native upstream SD sequences,
CmR
This study
pAA308 pMMB208 with chimeric yopN287(F+1)tyeA-flag®including native upstream SD sequences, CmR This study
pAA309
pMMB208 with chimeric yopN287(F+1), SDtyeA-
flag® including native upstream SD sequences,
CmR
This study
pUA066
pNQ705-derived mutagenesis vector for the
construction of a polar insertion in YPK_3687,
CmR
This study
pDM4 Suicide vector with oriR6K, sacB, CmR [46]
pAA256 SalI/XbaI PCR fragment of tyeA with a in framedeletion of codons 19-59 in pDM4, CmR This study
pSF019 SalI/XbaI PCR fragment flanking upstream ofyopN and downstream of tyeA in pDM4, CmR This study
Functional YopN-TyeA Chimeras
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vector [46] following SalI-XbaI restriction. E. coli S17-1λpir
harbouring the different mutagenesis constructs were used as
the donor strains in independent conjugations with Y.
pseudotuberculosis parent (YPIII/pIB102) [47]. Appropriate
allelic exchange events were monitored by Cm sensitivity and
sucrose resistance. All mutants were confirmed by a
combination of PCR and sequence analysis. Significantly, each
variant was introduced in cis on the Y. pseudotuberculosis
virulence plasmid to ensure expression occurred in the context
of native regulatory elements.
To generate a polar mutation in the YPK_3687 locus of
various Y. pseudotuberculosis YPIII derived strains, we used
the pUA066 mutagenesis vector. The pUA066 construct is
based on pNQ705 and was generated by digestion with SalI/
XbaI and then ligation of a DNA fragment that was PCR
amplified with the primer pair combination of pFpNQ066 and
pRpNQ066 (Table S1) using DNA template derived from a
boiled lysate of Y. pseudotuberculosis IP32953. Conjugal
transfer of pUA066 into Yersinia involved a mating with E. coli
S17-1λpir carrying the mutagenesis vector. Disruption of
YPK_3687 occurred via a single homologous recombination
cross-in of pUA066. Verification of the disruption utilised PCR
Table 1 (continued).
Strains and
plasmids Relevant genotype or phenotype
Source or
reference
pAA251
SalI/XbaI PCR fragment of yopN with a missense
mutation at codon 286 (LysAAA→IleATA) in pDM4,
CmR
This study
pAA242
SalI/XbaI PCR fragment of yopN with a +1
frameshift deletion mutation (‘T’) after codon 278
in pDM4, CmR
This study
pAA243
SalI/XbaI PCR fragment of yopN with a +1
frameshift deletion mutation (‘T’) after codon 278
and the conservative mutations at codons 283 and
284 (GlnCAG→CAA and ArgAGG→CGT) in pDM4,
CmR
This study
pAA247
SalI/XbaI PCR fragment of yopN with a +1
frameshift deletion mutation (‘A’) after codon 287
in pDM4, CmR
This study
pAA248
SalI/XbaI PCR fragment of yopN with a +1
frameshift deletion mutation (‘T’) after codon 278
and the conservative mutations at codons 283,
284 and 285 (SerTCA→TCC, GluGAG→GAA and
GlyGGT→GGC) in pDM4, CmR
This study
pAA252
SalI/XbaI PCR fragment of yopN with a
conservative mutation at codon 278
(PheTTT→PheTTC) in pDM4, CmR
This study
pAA253
SalI/XbaI PCR fragment of yopN with a missense
mutation at codon 279 (TrpTGG→PheTTC) in
pDM4, CmR
This study
pAA254 SalI/XbaI PCR fragment of yopN with a deletion ofcodon 278 in pDM4, CmR This study
pAA255 SalI/XbaI PCR fragment of yopN with a deletion ofcodon 279 in pDM4, CmR This study
doi: 10.1371/journal.pone.0077767.t001
and a series of primer combinations including a pair intended to
amplify the entire YPK_3687 open reading frame and another
combination designed to amplified the 5-prime end of the
YPK_3687, including the upstream flanking region, and part of
the integrated pUA066 vector.
Analysis of In Vitro Yop Synthesis and Secretion
Analysis of Yop synthesis and secretion by Y.
pseudotuberculosis followed the procedure as previously
described [45]. Samples of culture suspensions were taken to
represent the total protein fraction, whereas the cleared
bacteria-free supernatant corresponds to the secreted Yops
fraction. Primary rabbit polyclonal antibodies recognizing YopN,
YopD, YopE and DnaK were all a gift of Hans Wolf-Watz
(Umeå University, Sweden), while those recognizing TyeA
were a gift of Gregory Plano (University of Miami, USA).
Detection used anti-rabbit antiserum conjugated with horse
radish peroxidase (GE Healthcare, Buckinghamshire, United
Kingdom) and Thermo Scientific Pierce ECL 2 Western Blotting
Substrate to detect individual protein bands by western blotting.
Intracytoplasmic Stability Assay
Intrabacterial protein stability was assessed by the method of
Feldman and colleagues using Cm as the de novo protein
synthesis inhibitor [48]. Protein fractions were analyzed by
SDS-PAGE and Western blot. Steady state accumulated YopN
or YopN-TyeA hybrid was detected by treatment of the PVDF
membrane with rabbit polyclonal YopN antiserum, in
combination with horseradish peroxidase conjugated anti-rabbit
antibodies (Amersham Biosciences) and a homemade luminol-
based detection kit.
Generation of Constructs for Ectopic Expression of
YopN and TyeA
Lysates of Yersinia parent and mutant bacteria was used in
PCR to amplify the overlapping yopN and tyeA alleles on a
single DNA fragment using the primer pair combinations listed
in Table S1. Fragments were digested with BamHI and EcoRI
prior to ligation with similarly digested pMMB208 [49].
Confirmed clones were stored in E. coli S17-1λpir, which was
also used as donor in conjugal matings to mobilise the
expression constructs into the ΔyopN, tyeA double mutant
(YPIII/pIB8201a).
Low Calcium Growth Measurements
The ability of Yersinia to grow at 37°C under high- and low-
Ca2+ conditions was performed by measuring absorbance at
600nm (A600) of bacterial cultures grown in liquid Thoroughly
Modified Higuchi’s (TMH) medium (minus Ca2+) or TMH
medium supplemented with 2.5 mM CaCl2 (plus Ca2+) [50].
Growth phenotypes were compared to parental Y.
pseudotuberculosis (YPIII/pIB102), which is defined as calcium
dependent (CD), since it is unable to grow in the absence of
Ca2+ at 37°C, and Yersinia lacking the yscU and lcrQ alleles
(YPIII/pIB75-26) which is termed temperature sensitive (TS)
reflecting its inability to grow at 37°C [45].
Functional YopN-TyeA Chimeras
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YscF Surface Localization and Chemical Crosslinking
Overnight cultures from Yersinia strains were grown with
shaking at 26°C in 2 ml of BHI broth supplemented with 2.5mM
CaCl2. Subsequently, 0.1 volumes of bacterial suspension were
sub-cultured into 3 ml fresh media and incubated for 3 hour at
37°C. After each culture was standardized by A600, 1 ml
volumes were harvested by centrifugation at 8000g for 5 min at
4°C. Each bacterial pellet was gently resuspended in 1 ml of
cold 20 mM HEPES, 2.5 mM CaCl2 (pH 8). Bacterial surface
proteins were cross-linked for 30 min at ambient temperature
with the non-cleavable, membrane-impermeable, amine-
reactive cross-linker Pierce bis(sulfosuccinimidyl)suberate
(BS3) (Thermo Scientific) at a final concentration of 5 mM.
Cross-linking reactions were quenched for 15 min by addition
of Tris-HCl (pH 8.0) to a final concentration of 20 mM. Cell
fractions were collected by centrifugation at 12200g for 5 min at
4°C. Bacterial pellets were then resuspended in 100 µl of 1x
SDS-PAGE loading buffer (50mM Tris-HCl, pH 6.8, 2% SDS,
0.1% Bromophenol blue, 10% Glycerol, 5% β-
Mercaptoethanol) and analyzed by 18% acrylamide SDS
PAGE and immunoblotting with rabbit anti-YscF polyclonal
antiserum (a gift from Hans Wolf-Watz) that underwent several
rounds of immunoadsorption with purified YscF to enhance its
monospecificity.
Non-Polarized Secretion During Target Cell Contact
Cultivation and infection of HeLa cell monolayers was
performed using our standard methods [51,52]. After 3 hours
post-infection, 500 µl from the overlaying DMEM media was
carefully collected, clarified by centrifugation for 10 min at 4 °C,
and the bacterial-free supernatant representing the secreted
protein fraction was added to 4x SDS-PAGE sample buffer
(200mM Tris-HCl, pH 6.8, 8% SDS, 0.4% Bromophenol blue,
40% Glycerol, 20% β-Mercaptoethanol). To detect total protein
levels, the infected HeLa cells were harvested directly into 125
µl of 4x SDS-PAGE loading buffer. Equivalent volumes of the
total and soluble fractions were subjected to SDS-PAGE and
western blotting. Comparable loading was confirmed by using
mouse monoclonal antibodies specific for the eukaryotic
protein β–actin (Clone AC-74, Sigma-Aldrich). Yop levels were
detected using rabbit polyclonal anti-YopE and anti-YopD
antisera. By comparing the amount of protein secreted into the
extracellular media (soluble fraction) to the total synthesized
protein induced upon bacteria-host cell contact (total whole cell
lysates fraction), the proportion of YopE and YopD secreted
into the media and thus the degree of non-polarized secretion
can be estimated. The assay does not measure effector
injection capacities, so the degree of polarized translocation of
the YopE cytotoxin directly into the host cell cytosol remains
unknown. Placebo controls utilized mock infections with
bacteria in the absence of cell monolayers and cell monolayers
in the absence of bacteria.
Bacterial Viability in the Presence of Eukaryotic Cells
A modified method of Bartra and co-workers [53] as
described in earlier studies [45,54,55] was used to establish
bacterial viability in the presence of murine macrophage-like
J774 cells. In essence, bacteria lacking a fully functional T3SS
are more readily phagocytosed and are therefore more
susceptible to the antimicrobial effects of J774 cells. This
reduced viability was determined by performing colony forming
unit (CFU) counts for relevant bacterial strains in infected
eukaryotic cell lysates.
Mouse Co-Infections and Competitive Index
Measurements
Disruption by polar insertion of the gene encoding for a 349
amino acid inner membrane oligo-dipeptide/nickel ABC
transporter permease (annotated as YPTB0523 in Y.
pseudotuberculosis IP32953) has no measurable effect on
Yersinia virulence in the mouse model neither in single strain
infections nor in competitive infections with the isogenic wild-
type strain (UA, unpublished). Therefore, this mutation was
introduced into our mutants by a single cross-over of the
pUA066 mutagenesis plasmid. As well as creating a polar
mutation in the equivalent gene in Y. pseudotuberculosis YPIII
(annotated as YPK_3687), integration of the mutagenesis
plasmid conferred to these newly generated double mutants a
CmR marker for counter-selection against CmS parental
bacteria. Retention of the pIB102 virulence plasmid was
verified with our standard in vitro Ysc-Yop synthesis and
secretion assay. Comparable growth rates (monitored by A600)
and corresponding CFU counts of all bacteria were also
performed.
Female eight-week-old BALB/c mice (Taconic, Denmark)
were given food and water ad libitum. Then groups of five mice
were deprived of food and water 16 h prior to oral infection. For
infection, bacteria were grown overnight in 50 ml LB broth at
26°C, then pelleted and serially diluted in sterile tap water
supplemented with 150 mM NaCl. Serial dilutions were plated
to record CFU/ml and their corresponding A600 measured to
establish the volume of culture needed to inoculate 50 ml of
sterile drinking water with 2.5 x 109 viable mutant bacterial cells
(CmR) and 2.5 x 109 viable parental bacterial cells (CmS). Mice
were allowed to drink from this inoculated water for 6 hours.
Measurement of CFU was again performed to calculate the
amount of CmR bacteria in the inoculation water, which was
expressed as an input percentage of the total inoculated dose
(CmS + CmR). At day 4 post infection, spleens were harvested
aseptically in sterile PBS, homogenized, and plated for
bacterial CFU analysis to determine the amount of viable CmR
bacteria, and this was expressed as an output percentage of
the total recovered population. In turn, the competitive index
was determined as the ratio of percent CmR output versus
percent CmR input.
Ethics Statement
The infection studies were performed in strict accordance
with the Swedish Bioethical Guidelines for care and use of
laboratory animals. The protocol was approved by The Umeå
Committee on the Ethics of Animal Experiments (Permit
Number: A-60-10).
Functional YopN-TyeA Chimeras
PLOS ONE | www.plosone.org 6 October 2013 | Volume 8 | Issue 10 | e77767
Results
Y. pseudotuberculosis Naturally Produce and Secrete a
YopN-TyeA Hybrid
Y. pestis can produce and secrete a singular polypeptide
consisting of a ~42 kDa hybrid of YopN and TyeA that was the
result of a +1 frame shift during translation of the 3´-end of the
yopN mRNA [39]. This hybrid was also a substrate of the Ysc-
Yop T3SS. In contrast, a similar hybrid was not produced by Y.
enterocolitica because any +1 frame-shift along the yopN
mRNA would result in a premature stop codon immediately
upstream of, and in the same reading frame as translated tyeA
mRNA [39]. However, the yopN nucleotide sequences from Y.
pseudotuberculosis and Y. pestis are identical (Figure 2). This
would suggest that Y. pseudotuberculosis could also naturally
produce a YopN-TyeA product. To examine for this, bacteria
were grown in BHI broth restrictive (with Ca2+) or permissive
(without Ca2+) for T3S to examine the in vitro synthesis and
secretion profile of YopN. During growth in T3S permissive
conditions, parental Y. pseudotuberculosis could produce and
secrete a ~32 kDa protein that is YopN (Figure 3A).
Interestingly, an additional Ca2+-regulated slower migrating
band of ~42 kDa in both synthesis and secretion fractions was
also recognized by the anti-YopN antisera; this band is
consistent with the expected mass of a YopN-TyeA hybrid
protein (Figure 3A). Critically, this band was not observed in
synthesis and secretion fractions derived from an isogenic
mutant of Y. pseudotuberculosis lacking both yopN and tyeA or
from parental Y. enterocolitica (Figure 3A).
In an effort to confirm natural YopN-TyeA chimeric
production, initially we used anti-TyeA polyclonal antibodies to
directly detect in cis production of native singular TyeA (~11
kDa) or native TyeA produced as a hybrid (~42 kDa). However,
in our hands this was unsuccessful (data not shown), possibly
due to low level production or a high rate of TyeA turnover. To
circumvent this, we ectopically expressed the native yopN and
tyeA alleles from an IPTG inducible promoter harboured on the
pMMB208 expression plasmid (pAA304). Despite uncoupling
regulatory control from the Ysc-Yop regulators, the gene
synteny remained identical to that present on the virulence
plasmid. From lysates derived from the ΔyopN, tyeA null
mutant ectopically co-producing native YopN and TyeA, a ~42
kDa product in both synthesis and secreted fractions could be
detected with anti-TyeA (Figure 3B). Additionally, the anti-TyeA
antibodies also detected a diffuse band representing the free
~11 kDa TyeA product in the synthesis fraction only (Figure
3B).
To further confirm the contributions of both yopN and tyeA
sequence in this hybrid, using site-directed mutagenesis the 3-
prime yopN nucleotide sequence of Y. pseudotuberculosis was
manipulated to generate the substitution K286I that resembled
the yopN allele from Y. enterocolitica, which does not naturally
produce the YopN-TyeA hybrid (Figure 2) [39]. The resulting
mutant producing the YopNYpsYen variant failed to produce or
secrete a ~42 kDa product either when produce in cis (Figure
3A) or in trans when produced under the control of an IPTG
inducible promoter harboured on the pMMB208 expression
plasmid (pAA305) (Figure 3B). However, the free ~32 kDa
product of singular YopN (Figure 3A) and ~11 kDa product of
free TyeA (Figure 3B) were synthesized as normal.
Interestingly, the inability to produce the ~42 kDa YopN-TyeA
product in bacteria producing YopNYpsYen did not negate the
ability of these bacteria to maintain Ca2+-dependent control
over the synthesis and secretion of middle and late Yop
substrates, such as YopD and YopE respectively (Figure 3C).
In contrast, complete removal of the yopN and/or tyeA alleles
lead to the constitutive synthesis and secretion of YopD and
YopE (Figure 3C and data not shown). Moreover, bacteria
lacking tyeA could not maintain steady state levels of YopN
(Figure 4A), suggesting that YopN stability and function
depends on the presence of TyeA. We also confirmed that
steady state levels of YopNYpsYen were equivalent to native
YopN (Figure 4A).
Taken together, these data are all consistent with the ability
of Y. pseudotuberculosis to naturally produce a ~42 kDa YopN-
TyeA singular polypeptide presumably as a result of a +1 frame
shift during translation of the 3´-end of yopN mRNA. Moreover,
this product undergoes Ca2+-regulated secretion via the Ysc-
Yop T3SS. This corroborates occurrence of a similar sized
product produced and secreted by the Ysc-Yop system in Y.
pestis [39].
Stable Production of Genetically Engineered YopN-
TyeA Chimeras in Y. pseudotuberculosis
In prokaryotes (including viruses) and eukaryotes,
programmed frame-shifting events are an important
translational control mechanism for regulating the production of
diverse functioning proteins [56-60]. The ~42 kDa hybrid
protein naturally produced by Y. pestis and Y.
pseudotuberculosis involved a frame-shifting event that fused
the translation of yopN to overlapping tyeA, the products of
which are essential mediators of T3S control. Although the
levels of hybrid production and secretion are significantly lower
than when produced as separate entities, we wondered if this
hybrid is biologically relevant for T3S function in Yersinia. In
order to investigate this, we utilized site directed mutagenesis
to engineer in cis mutations in yopN that resulted in the artificial
production of predominantly YopN-TyeA chimeras by Y.
pseudotuberculosis. The first mutation was a +1 frame-shift
directly introduced after yopN codon 278 by removal of a single
‘T’ nucleotide. This generated bacteria that produced a YopN-
TyeA fusion – designated YopN 278(F+1)TyeA – that consisted of
native YopN amino acid until residue 278, followed by an
altered sequence between residues 279 and 287, prior to the
switch to TyeA specific coding sequence (Figure 2). This
means that the extreme YopN C-terminus encompassing
residues 288 to 293 are replaced by unadulterated N-terminal
TyeA sequence. Similarly, a second strain was generated by
introducing a +1 frame shift after yopN codon 287 by removal
of an ‘A’ nucleotide located immediately upstream of the tyeA
start codon. The result was a bacterium able to produce a
YopN-TyeA fusion termed YopN 287(F+1)TyeA, which
incorporated native YopN sequence until residue 287, but was
then followed by TyeA sequence. Once again, the extreme six
residue YopN C-terminus was replaced by the beginning of
TyeA (Figure 2). As these two mutants still left upstream of
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Figure 2.  Region of sequence overlap between YopN and TyeA.  Comparison of the nucleotide and amino acid sequence in
YopN and TyeA derived from Y. pseudtotuberculosis (Yps), Y. pestis (Ype) and Y. enterocolitica (Yen) (boxed panel). Nucleotide
sequence of the sense strand is given in lower case font with identity between yopNYps/Ype sequence and yopNYen sequence indicated
by the colon symbol (:). Numbers indicated they amino acid sequence that is given in upper case font either above (for yopNYps/Ype)
or below (for yopNYen) the gene sequence. The yopN termination codon is indicated by red highlight and the tyeA initiation codon in
green highlight and the upstream putative Shine-Dalgarno sequence is boxed. The first 10 amino acid residues of TyeA are identical
in all three Yersinia species. As described by others [39], the putative pausing site (‘ttttgg’) for instigating a +1 frame-shift to create a
YopN-TyeA hybrid is presented in magenta highlight. The out-of-frame stop codon (‘taa’) just upstream of the tyeA start that would
prevent hybrid formation via +1 frame-shifting in Y. enterocolitica is given in red font. Shown below the boxed panel are the
mutations used to modulate YopN-TyeA hybrid formation in Y. pseudotuberculosis. The first mutation was a missense mutation (▼)
at codon 286 (LysAAA→IleATA) to introduce an out-of-frame ‘taa’ stop codon that abolished hybrid formation (YPIII/pIB8214;
YopNYps→Yen). The second mutation was a +1 frameshift deletion mutation (removal of ‘T’) after codon 278 (↓) to give a YopN278(F
+1)TyeA chimera (YPIII/pIB8205). The third mutation was a +1 frameshift deletion mutation (‘T’) after codon 278 (↓) combined with
conservative mutations (▼) at codons 283 and 284 (GlnCAG→CAA and ArgAGG→CGT) that partially disrupts the presumed tyeA Shine-
Dalgarno sequence to give a YopN278(F+1), SDTyeA chimera (YPIII/pIB8206). The fourth mutation was a +1 frameshift deletion
mutation (removal of ‘A’) after codon 287 (↓) to give a YopN287(F+1)TyeA chimera (YPIII/pIB8210). The fifth mutation was the same
+1 frameshift deletion mutation (removal of an ‘A’) after codon 2878 (↓) combined with conservative mutations (▼) at codons 283,
284 and 285 (SerTCA→TCC, GluGAG→GAA and GlyGGT→GGC) that partially disrupts the presumed tyeA Shine-Dalgarno sequence to give a
YopN287(F+1), SDTyeA chimera (YPIII/pIB8211). Altered amino acid sequence in YopN prior to the tyeA initiation codon is indicated in
blue highlight. Gray highlight reflects the cessation of TyeA production as a singular polypeptide courtesy of disrupting its upstream
Shine-Dalgarno sequence.
doi: 10.1371/journal.pone.0077767.g002
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tyeA an uncharacterised but intact putative Shine Dalgarno
(SD) sequence, albeit displaced by n−1 in the second mutant,
they could conceivably still produce trace amounts of TyeA as
a single (free) polypeptide entity. This was addressed by
generating two additional mutants in which this putative SD
sequence was conservatively ‘scrambled’ as much as possible
without altering the yopN coding sequence. This resulted in two
new mutants designated YopN 278(F+1), SDTyeA and YopN 287(F+1),
SDTyeA respectively (Figure 2).
The stability of these four chimeras in the presence of
endogenous proteases was examined. The larger ~42 kDa
products synthesized in cis were easily detectable with anti-
YopN antisera and remained as stable as the smaller ~32 kDa
singular YopN polypeptide produced by parental Y.
pseudotuberculosis (compare Figure 4B with Figure 4A).
Additionally, all larger synthetic ~42 kDa variants accumulated
in greater abundance, in contrast to the natural hybrid product
that was barely detectable (Figure 4B). At this stage we have
no firm grasp on why this might be the case. To determine
whether the engineered YopN-TyeA(~42 kDa) variants
displayed similar stability to the naturally formed hybrid
produced by the parental strain, it was therefore necessary to
establish a series of expression constructs that placed the
various overlapping yopN and tyeA alleles PCR amplified from
parent and mutant bacteria under an IPTG promoter on
pMMB208. Ectopic in trans expression in the ΔyopN, tyeA
double mutant now afforded sufficiently elevated production
levels to detect stability of the natural hybrid (Figure 4C).
Figure 3.  Analysis of naturally produced YopN-TyeA hybrid synthesis and secretion by Y. pseudotuberculosis.  Overnight
cultures of Y. pseudotuberculosis were sub-cultured into BHI medium in the presence (+) or absence (-) of calcium ions at 26°C for
1 hour and at 37°C for 3 hours. Protein in the total bacterial suspension (Synthesis) and free in the cleared culture supernatant
(Secretion) were collected, fractionated by 12% acrylamide SDS-PAGE, wet-blotted onto PDVF membrane and then detected using
rabbit polyclonal anti-YopN (A), anti-TyeA (B) and also anti-YopD and anti-YopE (C) antibodies. The arrow (←) is pointing toward
the ~42 kDa YopN-TyeA hybrid. The open (∇) arrowhead identifies non-specific protein bands uniquely recognised by the anti-YopN
and anti-TyeA antisera in protein samples derived from Y. pseudotuberculosis. The closed (▼) arrowhead indicates a non-specific
protein band recognised by the anti-YopN antiserum in protein samples derived from Y. enterocolitica. The asterisk (*) highlights the
altered mobility of the YopD product derived from Y. enterocolitica. In A and C, lanes are represented by: Parent (YopNYps), Y.
pseudotuberculosis YPIII/pIB102; Parent (YopNYen), Y. enterocolitica 8081/pYVe8081; YopNYps→Yen, Y. pseudotuberculosis YPIII/
pIB8214; ΔyopN, tyeA, YPIII/pIB8201a. In B, lanes are Y. pseudotuberculosis ΔyopN, tyeA (YPIII/pIB8201a) also containing pYopN,
TyeA+ (pAA304), empty vector (pMMB208) or pYopN(Yps→Yen), TyeA+ (pAA305). Approximate molecular mass values shown in
parentheses were deduced from primary amino acid sequences.
doi: 10.1371/journal.pone.0077767.g003
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Figure 4.  Intrabacterial stability of pre-formed pools of genetically engineered YopN-TyeA chimeras.  Bacteria were first
cultured for 1 hour in non-inducing (plus 2.5 mM CaCl2) BHI broth at 37°C either without (A and B) or with 0.4 mM IPTG (C). The
protein synthesis inhibitor chloramphenicol (50 µg/ml) was added at time point 0 minutes (min). Samples were then collected at this
and subsequent time points. Protein levels associated with pelleted bacteria were detected by Western blot using polyclonal anti-
YopN antiserum to detect singular YopN produced in cis (A) or YopN produced as a hybrid with TyeA derived from in cis production
(B) or IPTG inducible ectopic in trans production (C). Note that the majority of samples in C were diluted by a factor of 25 to reduce
the amount of material subjected to gel fractionation. In A, samples are derived from: Parent (YopNYps), YPIII/pIB102; ΔyopN, YPIII/
pIB82; ΔtyeA, YPIII/pIB801a; YopNYps→Yen (YopNK286I), YPIII/pIB8214. In B, samples are derived from: Parent (YopNYps), YPIII/
pIB102; YopN 278(F+1)TyeA, YPIII/pIB8205; YopN 278(F+1), SDTyeA, YPIII/pIB8206; YopN 287(F+1)TyeA, YPIII/pIB8210; YopN 287(F+1), SDTyeA,
YPIII/pIB8211. In C, samples are derived from Y. pseudotuberculosis ΔyopN, tyeA (YPIII/pIB8201a) also containing pYopN, TyeA+
(pAA304), pYopN278(F+1), TyeA+ (pAA306), pYopN278(F+1), SD, TyeA+ (pAA307), pYopN287(F+1), TyeA+ (pAA308), or pYopN287(F+1), SD, TyeA
+ (pAA309). Approximate molecular mass values shown in parentheses were deduced from primary amino acid sequences.
doi: 10.1371/journal.pone.0077767.g004
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Although it was necessary to load 25 times less protein
material derived from the synthetic YopN-TyeA chimeric strains
(i.e. diluted by a factor of 25) compared to the parental strain,
their stability was essentially comparable to the native hybrid
with the exception of YopN287(F+1), TyeA that was a little less
stable (Figure 4C).
Since free TyeA could be functional and bias the behavior of
individual synthetic YopN-TyeA hybrids, it was also necessary
to explore its status in the constructed strains. Antibodies
raised against TyeA recognized the in cis produced ~42 kDa
band representing artificially produced chimeric YopN-TyeA
hybrids, but not the ~11 kDa band of free TyeA from these
mutants or from parental bacteria (data not shown). To
circumvent this, the pMMB208-derived expression constructs
described for the stability assays (see Fig 4C) were again used
to measure TyeA synthesis and secretion. Using anti-TyeA
antibodies, we could once more detect high levels of the ~42
kDa band when ectopically expressed in Yersinia lacking yopN
and tyeA (Figure S1). In contrast, the ~11 kDa band of free
TyeA was clearly detected only when co-expressing the native
yopN and tyeA alleles in the synthesis fraction, with possibly
very low level expression of free TyeA detectable from the two
constructs expressing the hybrids YopN 287(F+1)TyeA and YopN
287(F+1), SDTyeA (Figure S1). Thus, if any free TyeA is produced
in the four engineered chimeric strains, it is so low as to be
essentially undetectable by western blot and consequently
would likely not interfere with the function of YopN that is
produced as part of the YopN-TyeA hybrid.
Hence, it was evident from this series of experiments that we
successfully genetically manipulated Y. pseudotuberculosis to
specifically produce a range of stable YopN-TyeA chimeras
suitable to investigate their functional relevance to Yersinia
biology.
Secreted YopN-TyeA Hybrids Maintain In Vitro Yops
Secretion Control
The current working hypothesis suggests that a tetra-
complex of YopN, together with the cognate T3S chaperones
YscB and SycN, as well as TyeA act together as a secretion
plug located at the cytoplasmic face of the inner membrane to
prevent entry of Yop substrates into the secretion channel
[34-36,38]. When the T3S apparatus is competent for
secretion, environmental cues such as target cell contact or
calcium depletion are anticipated to alter conformation of the
YscF needle in a way that permits secretion of YopN. Once the
secretion plug is removed, the T3SS can engage with and
secrete the raft of middle and late Yop substrates. Thus, to
investigate the impact of YopN-TyeA chimera production on
T3SS activity, we began by investigating the degree to which
the YscF needle component was secreted and polymerized at
the bacterial surface – the final step in the assembly of an
active Ysc-Yop T3SS. In our assay, visualization of YscF
polymerization was aided by the presence of the non-
membrane permeable chemical crosslinker BS3. With the
exception of the yscF null mutant used as an antibody
specificity control, monomeric YscF that was located in the
bacterial cytoplasm and protected from the membrane
impermeable crosslinker was detected in all samples (Figure
S2). Parental bacteria could also secrete YscF that was readily
cross-linked by BS3 to form higher order structures indicative of
the T3S needle (Figure S2). In contrast, surface-located YscF
was completely absent in the T3SS-defective full-length yscU,
lcrQ deletion mutant, even though cytoplasmic located
monomeric YscF protected from the non-membrane permeable
crosslinker was visualized (Figure S2). Critically, YopN-TyeA
chimera production by bacteria did not impact on their ability to
produce higher order YscF structures at the bacterial surface
(Figure S2). Hence, chimeric-produce bacteria assemble the
Ysc-Yop T3SS that is competent for secretion of early
substrates such as the YscF needle component.
Next we examined if the YopN-TyeA chimeras could be
secreted by the assembled T3SS during bacterial growth in
BHI broth restrictive (plus Ca2+) and permissive (minus Ca2+) for
T3S. Having already confirmed by western blot the presence of
both YopN and TyeA sequence in the synthetic hybrids, for
convenience we used only anti-YopN antisera in subsequent
western blot analyses of their synthesis and secretion profiles.
Parental bacteria produced and secreted both YopN alone (~32
kDa) and a YopN-TyeA hybrid (~42 kDa) (Figure 5A). Once
again, it was evident that the engineered ~42 kDa YopN-TyeA
hybrids accumulated to greater levels than did the smaller ~32
kDa singular YopN polypeptide (Figure 5A). As noted earlier
[34,61,62], a ΔtyeA null mutant has lost control of T3S activity,
producing and secreting YopN during growth in both low and
high calcium media (Figure 5A). Interestingly, the ΔtyeA null
mutant also produced a smaller YopN-TyeA20-59 hybrid product,
consistent with the reduced size of truncated and inactivated
TyeA (Figure 5A). Secretion was T3SS-dependent because a
strain devoid of the YscU – an integral inner membrane
component of the Ysc-Yop T3SS – failed to secrete YopN.
Interestingly, YopN-TyeA hybrid producing bacteria did not
cause any deviation in the synthesis and secretion profiles of
the so-called middle (e.g. YopD) and late (e.g. YopE) Yop
substrates, since they were all comparable to parental bacteria
(Figure 5B). On the other hand, the single ΔyopN and ΔtyeA
mutants along with the double ΔyopN, tyeA mutant had all lost
general control with Yop substrate synthesis and secretion
being constitutive regardless of the calcium concentration
(Figure 5B). Thus, it appears that engineered YopN-TyeA
hybrids all have the capacity to maintain tight control over Yop
secretion reminiscent of when they are produced as two
separate polypeptides [34-36]. This happens despite the higher
steady-state accumulation of each individual hybrid. At this
stage, we can only speculate that the reason for increased
protein levels involves some aspect of translation efficiency
and/or product stability not measurable by assays utilized in
this study.
Deregulated defects in Yop secretion control correspond to
aberrant growth patterns in low calcium at elevated
temperature. Therefore, in parallel we measured growth of our
Yersinia mutants in TMH growth medium (low calcium) and
supplemented with 2.5 mM CaCl2 (high Ca2+) at 37 °C. Growth
of parental bacteria followed a typical calcium-dependent
profile, where growth was observed only in the presence of
calcium (Figure S3). Significantly, this was similar to the growth
profiles of all four YopN-TyeA hybrid producing bacteria (Figure
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S3), corroborating their intact Yops secretion control. In
contrast, the single ΔyopN and ΔtyeA mutants along with the
double ΔyopN, tyeA mutant that no longer had control over
Yops synthesis and secretion, were all rendered completely
temperature sensitive for growth regardless of a high or low
Ca2+ concentration (Figure S3). Altogether, these data suggest
that YopN-TyeA hybrids maintain yop regulatory control, at
least during growth under these standard laboratory conditions.
YopN-TyeA Hybrid Function in Effector Translocation
Although recently challenged by a study proposing a two-
step translocation model [63], Yop effector delivery into target
eukaryotic cells has long been considered a one-step polarized
mechanism that avoids wasteful effector substrate secretion
into the extracellular environment [43,64,65]. In fact, yopN or
tyeA mutant bacteria that have lost the ability to control Yop
secretion in vitro also secrete Yops in a non-polarized fashion
into the extracellular milieu when in contact with eukaryotic
cells. As a result, subsequent yopN and tyeA mutant effector
injection capacities are reduced [34,61,62,64,66]. Hence, the
degree of non-polarized Yops secretion during host cell contact
by Y. pseudotuberculosis producing hybrid YopN-TyeA
polypeptides was measured. We compared two different
fractions from infected HeLa cell monolayers; the first was the
clarified extracellular supernatant (non-polarized secreted
protein fraction) and the second was whole cell lysates (total
protein fraction associated with bacteria, HeLa cells and in the
supernatant). Very little Yops were detected in the supernatant
fraction of HeLa cell infections with parental Y.
pseudotuberculosis, despite high levels of protein available in
the total protein pool (Figure 6). This observation reflects the
central tenet that Yops are directly delivered into cells and are
seldom released free into the environment. This contrasts with
the yopN and/or tyeA deletion mutants that liberate far greater
amounts of Yop material free into the extracellular environment
(Figure 6), which is indicative of their reduced effector injection
Figure 5.  Analysis of YopN-TyeA hybrid synthesis and secretion.  Overnight cultures of Y. pseudotuberculosis were sub-
cultured into BHI medium in the presence (+) or absence (-) of calcium ions at 26°C for 1 hour and at 37°C for 3 hours. Protein in
the total bacterial suspension (Synthesis) and free in the cleared culture supernatant (Secretion) were collected, fractionated by
12% acrylamide SDS-PAGE, wet-blotted onto PDVF membrane and then detected using rabbit polyclonal anti-YopN (A) and also
anti-YopD and anti-YopE (B) antibodies. The arrow (→) point towards a non-specific protein band recognised by the anti-YopN
antiserum. The single asterisk (*) highlights the single YopN polypeptide, while the double asterisk (**) indicates the larger YopN-
TyeA hybrid protein. Lanes: Parent (YopNYps), YPIII/pIB102; ΔyscU, lcrQ double mutant, YPIII/pIB75-26; ΔyopN null mutant, YPIII/
pIB82; ΔtyeA null mutant, YPIII/pIB801a; ΔyopN, tyeA double mutant, YPIII/pIB8201a; YopN 278(F+1)TyeA, YPIII/pIB8205; YopN 278(F
+1), SDTyeA, YPIII/pIB8206; YopN 287(F+1)TyeA, YPIII/pIB8210; YopN 287(F+1), SDTyeA, YPIII/pIB8211. Approximate molecular mass
values shown in parentheses were deduced from primary amino acid sequences.
doi: 10.1371/journal.pone.0077767.g005
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capacities as described previously [34,61,62,64,66]. For
reasons currently unknown, Y. pseudotuberculosis lacking tyeA
display greater de-repression than does the single yopN
mutant. For bacteria producing engineered YopN 278(F+1)TyeA
and YopN 278(F+1), SDTyeA hybrid polypeptides, their capacity for
Yops translocation was inferior as evidenced by the slight
elevation in non-polarized Yops secretion into the extracellular
environment during infection of tissue culture cell monolayers
(Figure 6). In contrast, bacteria producing either YopN 287(F
+1)TyeA or YopN 287(F+1), SDTyeA still maintained polarized Yops
secretion suggesting that these bacteria deliver Yops into HeLa
cells with efficiencies reminiscent of parental bacteria (Figure
6). Hence, all four hybrid-producing bacteria maintain far
superior control over T3SS activity than do bacteria lacking
yopN and/or tyeA. The reduction observed for YopN 278(F
+1)TyeA and YopN 278(F+1), SDTyeA hybrid-producing bacteria is
consistent with these variants producing a YopN module
having the most altered C-terminal sequence (i.e. after codon
278; see Figure 2). Critically, this fault in target cell contact
stimulated T3S control is not evident when examining low Ca2+-
dependent induction in vitro in standard laboratory growth
medium (see Figure 5).
In parallel, we measured the capacity of our YopN-TyeA
hybrid producing bacteria to resist phagocytosis and killing by
J774A.1 macrophage-like immune cells [45,53-55], which is a
hallmark of Ysc-Yop T3S activity [67]. In principal, any bacteria
with a compromised T3SS will be phagocytosed by immune
cells, exposing these internalized bacteria to potent and
effective anti-microbial killing strategies. In contrast, an active
T3SS will protect bacteria from phagocytosis so they can
proliferate extracellularly. Bacterial infections were observed up
to 6h post-infection. At 2h and 6h post-infection, the viability of
bacteria associated with host cells was determined by
measuring colony forming units (CFU). Importantly, the
translocation defective and growth restricted ΔyopB, yopD null
mutant cannot resist immune cell phagocytosis and is
efficiently killed, which dramatically restricts the recovery of
viable bacteria at 2h (Figure 7A, P=0.0032, **) and again at 6h
post-infection (Figure 7B, P=0.0032, **). While not to the same
extent as the ΔyopB, yopD null mutant, removal of yopN and/or
tyeA is also a serious impediment to sustaining bacterial
viability in the face of immune cell activity at both early (Figure
7A, P<0.05, * and ***) and late time points (Figure 7B,
P<0.005, ***), corroborating severe defects in polarized
secretion of effector Yops (see Figure 6) [34,61,62,64,66]. On
the other hand, all four YopN-TyeA hybrid producing bacteria
efficiently resisted phagocytosis and killing by J774A.1
macrophage-like immune cells at both early and late time-
points to a similar degree as parental bacteria (Figure 7,
P>0.05, no significant difference). This suggests that the
deficiencies in polarized secretion observed for YopN 278(F
+1)TyeA and YopN 278(F+1), SDTyeA producing bacteria does not
impact negatively on their resistance to immune cell
engulfment and killing. When considered altogether, these in
vitro-based assays suggest that the YopN-TyeA hybrids can
support T3SS function.
Figure 6.  Polarized translocation of YopE by YopN-TyeA hybrid producing bacteria.  HeLa cells were infected with parental
and mutated Y. pseudotuberculosis strains. The cell-free culture supernatant (S) and total cellular material (T) was then analysed for
YopE and YopD by ECL-Western blot using rabbit anti-YopE and anti-YopD serum. The extent of eukaryote cell cytosolic material in
each fraction was indicated by a western blot probing for host derived β–actin. Lanes: No bacteria, Mock infection with HeLa cell
monolayer alone: Parent (YopNYps), YPIII/pIB102 either in the absence (−) or presence (+) of a HeLa cell monolayer; ΔyopN null
mutant, YPIII/pIB82; ΔtyeA null mutant, YPIII/pIB801a; ΔyopN, tyeA double mutant, YPIII/pIB8201a; YopN 278(F+1)TyeA, YPIII/
pIB8205; YopN 278(F+1), SDTyeA, YPIII/pIB8206; YopN 287(F+1)TyeA, YPIII/pIB8210; YopN 287(F+1), SDTyeA, YPIII/pIB8211. Approximate
molecular mass values shown in parentheses were deduced from primary amino acid sequences.
doi: 10.1371/journal.pone.0077767.g006
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Figure 7.  Formation of YopN-TyeA hybrids does not compromise in vitro T3SS activity.  Y. pseudotuberculosis strains were
used to infect murine macrophage-like J774-1 cells. Bacterial cells with a compromised T3SS were more rapidly phagocytosed and
killed by these immune cells. Bacterial viability as measured by CFU/ml was determined at 2 hours (A) and 6 hours (B) post-
infection and is expressed as a mean of 4 independent assays ± the standard deviation. Strains: Parent (YopNYps), YPIII/pIB102;
ΔyopB, yopD double mutant, YPIII/pIB619; ΔyopN null mutant, YPIII/pIB82; ΔtyeA null mutant, YPIII/pIB801a; ΔyopN, tyeA double
mutant, YPIII/pIB8201a; YopN 278(F+1)TyeA, YPIII/pIB8205; YopN 278(F+1), SDTyeA, YPIII/pIB8206; YopN 287(F+1)TyeA, YPIII/pIB8210;
YopN 287(F+1), SDTyeA, YPIII/pIB8211. Data sets were analyzed using the non-parametric two-tailed Mann-Whitney U-test. Analysis
was performed using GraphPad Prism version 5.00 for Windows. Differences between mutants and parent (yopNwt) with a p-values
< 0.05 were considered significant (*, ** and ***). ns – not statistically different.
doi: 10.1371/journal.pone.0077767.g007
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Virulence Attenuation of Yersinia Producing YopN-
TyeA Hybrids
If the YopN-TyeA hybrid can fully support Ysc-Yop T3S
function, then bacteria producing these should compete equally
well with parental bacteria for survival during co-infection of
mice. To facilitate these competition infection experiments, we
utilised our prior knowledge that CmR bacteria containing a
polar mutation within the gene encoding for a inner membrane
oligo-dipeptide/nickel ABC transporter permease (annotated as
YPTB0523 in Y. pseudotuberculosis IP32953) successfully
competes with parental bacteria for equal colonization of organ
tissues in orally infected mice (UA, unpublished). Therefore, we
introduced this polar mutation into the orthologous YPK_3687
locus (as annotated in Y. pseudotuberculosis YPIII) of our
temperature sensitive ΔyopN, tyeA mutant as well as all four
regulatory competent YopN-TyeA hybrid producing bacteria
and the YopNYpsYen producing bacteria (that can no longer
naturally produce any hybrid). This gave rise to six new strains
that now are all CmR to serve as a convenient selective marker
to distinguish them from the CmS parental bacteria during the
process of determining CFU counts derived from spleens
dissected on day 4 from groups of five mice orally co-infected
with a known input ratio of both parent (CmS) and mutant (CmR)
bacteria. As a control, we also co-infected with parental
bacteria (CmS) and the isogenic mutant containing only the
additional polar mutation introduced into the YPK_3687 gene
(CmR). As anticipated from unpublished data, a competitive
index (CI) value of 0.9 confirms that this YPK_3687 polar
mutation in parental bacteria (yopNwt), does not compromise
the ability of these CmR bacteria to compete with CmS parent
(also yopNwt) for systemic spreading and spleen colonization
(Figure 8 and Table S2) (UA, unpublished). On the other hand,
the CmR ΔyopN, tyeA mutant fared extremely poorly in
competition with the CmS parent containing the wild type yopN
allele (Figure 8 and Table S2; P=0.0079, **). At least in part,
the very low CI score of 0.00008 for the ΔyopN, tyeA mutant
reflects its inability to grow at body temperature. On the other
hand, YopNYpsYen producing bacteria possessed a CI score of
1.04 (Figure 8 and Table S2; P=0.8413). This suggests that
while singular YopN and TyeA are being produced, it matters
not whether these bacteria also produce the larger hybrid form.
Interestingly, the YopN 278(F+1)TyeA, YopN 278(F+1), SDTyeA, YopN
287(F+1)TyeA and YopN 287(F+1), SDTyeA hybrid producing bacteria
presented CI values of 0.096 (P=0.0317, *), 0.032 (P=0.0079,
**), 0.059 (P=0.0159, *) and 0.135 (P=0.0317, *) respectively,
which were all significantly lower than parental control bacteria
(Figure 8 and Table S2). Significantly, only two of these hybrid
producing bacteria were compromised in polarized secretion
(see Figure 6). Hence, these sensitive competitive survival co-
infection experiments revealed that all four YopN-TyeA hybrids
are not the functional equal of YopN and TyeA produced as
independent polypeptides; an observation missed when using
in vitro based assays that evidently lack the discriminatory
sensitivity to resolve subtle biologically relevant imperfections
in T3SS activity.
We were curious to identify a reason for the slight virulence
attenuation of the YopN-TyeA hybrid producing bacteria. The
fact that the hybrids YopN 278(F+1)TyeA and YopN 278(F+1), SDTyeA
displayed a subtle increase in non-polarized Yop secretion (see
Figure 6) hinted that the fine-tuning of Yop secretion control is
a reason for virulence attenuation. To investigate this, an in
vitro regulatory assay was designed that had an enhanced
discriminatory power over traditional T3S assays. Two IPTG-
inducible expression constructs based upon pMMB208 were
generated; the first contained native full-length and overlapping
yopN and tyeA alleles (pAA269) and the second with the
engineered yopN 278(F+1), SDtyeA allele (pAA271) whose hybrid
product caused the most virulence attenuation (see Figure 8
and Table S2). Using the fact that the ΔyopN, tyeA double
mutant is deregulated for Yop synthesis, even at the non-
permissive high Ca2+ conditions (see Figure 5), we examined
how efficient the two expression constructs were at restoring
feedback inhibitory control i.e. preventing Yops synthesis at
high Ca2+ conditions. We did this by progressively titrating into
the growth medium increasingly higher concentrations of IPTG.
It was very evident that as soon as ectopic singular YopN (~32
kDa) and TyeA (not shown) expression was detectable (using
as little as 0.01 mM IPTG) cessation of YopE and to a lesser
extent YopD synthesis occurred concomitantly (Figure 9A). In
contrast, although ectopic YopN 278(F+1), SDTyeA hybrid (~42
kDa) protein was detectable at an even lower IPTG
concentration (using as little as 0.04 mM IPTG), complete
cessation of YopE synthesis, and to a lesser extent YopD
synthesis, required at least a 5-fold higher IPTG concentration
than was used for native YopN and TyeA expression (Figure
9B). However, this delay in Yop synthesis inhibition cannot be
explained by insufficient accumulation of YopN 278(F+1), SDTyeA,
which was at least the equivalent of maximal levels of singular
YopN even at low IPTG doses. Hence, we can only assume
that the action of the hybrid in instigating repression –
presumably by resetting the YopN secretion plug in the channel
– is comparatively sluggish. Thus, we believe hybrid producing
mutants are routinely less fit in infected animals because they
are unable to respond rapidly to coordinate changes in Ysc-
Yop synthesis and secretion in accordance with environmental
flux encountered when in the host animal.
Establishing a Frame-shifting Mechanism for YopN-
TyeA Hybrid Production
The mechanism for formation of the naturally occurring
YopN-TyeA hybrid in Y. pestis was proposed to be a +1
translational frame-shifting event instigated by a putative
ribosomal pausing site ‘UUU-UGG’ encompassing codons F278
and W279 within the 3´-end of yopN mRNA [39]. Given the
existence of identical yopN sequence in Y. pseudotuberculosis
and Y. pestis (see Figure 2), one might assume for this
potential frame-shifting mechanism to be shared between the
two species. However, this could not be confirmed by mass
spectroscopy because our numerous attempts to determine the
protein sequence of native YopN-TyeA were fruitless (data not
shown), a situation also experienced by others [39]. Therefore,
we proceeded to target the putative ‘UUU-UGG’ ribosomal
pausing sequence by site-directed mutagenesis in Y.
pseudotuberculosis. Four yopN mutations were generated; the
first a silent FUUU FUUC mutation to give YopNF278F, the second a
missense WUGG FUUC mutation to give YopNW279F, while the
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Figure 8.  Competitive index for mice colonization.  Y. pseudotuberculosis mutants with defective yopN alleles as well as
parental bacteria (yopN+) were manipulated to confer resistance to chloramphenicol by virtue of introducing a polar mutation into the
YPK_3687 allele. These strains were used together with parental bacteria (CmlS) to co-infect groups of five mice via intentional
contamination of their drinking water. Bacteria recovered from extracted spleens were measured by CFU/ml after four days of
infection. The competitive indices (CI) were determined according to the footnotes in Table S2. Each symbol (•) reflects the CI
derived from an individual mouse and the horizontal line is the mean of five mice ± the standard error. Strains: Parent (YopNYps),
YPIII170/pIB102; YopNYps→Yen, Y. pseudotuberculosis YPIII170/pIB8214; ΔyopN, tyeA double mutant, YPIII170/pIB8201a; YopN 278(F
+1)TyeA, YPIII170/pIB8205; YopN 278(F+1), SDTyeA, YPIII170/pIB8206; YopN 287(F+1)TyeA, YPIII170/pIB8210; YopN 287(F+1), SDTyeA,
YPIII170/pIB8211. Note that all strains harbour a polar insertion in YPK_3687 (i.e. strain designation ‘YPIII170’).
doi: 10.1371/journal.pone.0077767.g008
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Figure 9.  Minimal level of YopN and TyeA required for regaining Yop synthesis control.  A deregulated yopN and tyeA double
mutant of Y. pseudotuberculosis (YPIII/pIB8201a) expressing either an IPTG inducible variant of native YopN and TyeA (A; pYopN+,
TyeA+) or an engineered YopN-TyeA hybrid (B; pYopN 278(F+1), SDTyeA+) was grown at 37 °C in T3S restrictive (+Ca2+) or T3S
permissive (−Ca2+) conditions. Protein associated with pelleted bacteria was fractionated by 12% acrylamide SDS–PAGE and
detected by Western blot using polyclonal anti-YopN, anti-YopD and anti-YopE antiserum. As a bacterial loading control we probe
levels of the cytoplasmic molecular chaperone DnaK with anti-DnaK antibodies. Variable ectopic expression of native YopN and
TyeA or the engineered hybrid variant was achieved via the incremental increase in the final concentration of IPTG added to the
growth media (0.001 mM, 0.002 mM, 0.003 mM, 0.004 mM, 0.005 mM, 0.01 mM, 0.02, mM, 0.025 mM, 0.03 mM, 0.035 mM, 0.04
mM, 0.045 mM, 0.05 mM, 0.1 mM, 0.2 mM and 0.3 mM respectively). The `−´ symbol indicates the absence of IPTG, while `+´
indicates a final concentration of 0.4 mM. Strains: Parent (YopNYps), YPIII/pIB102; ΔyopN, tyeA double mutant, YPIII/pIB8201a; The
single asterisk (`*´) indicates singular YopN, while the double asterisk (`**´) represents the YopN-TyeA hybrid variant. The arrow (→)
is pointing toward a non-specific protein band recognized by the anti-YopN antiserum. Approximate molecular mass values shown
in parentheses were deduced from primary amino acid sequences.
doi: 10.1371/journal.pone.0077767.g009
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remaining two were clean deletions of codon 278 and 279 to
give YopNΔ278F and YopNΔ279W, respectively. All four mutants
were grown in BHI media that was either T3S–restrictive (plus
Ca2+) or T3S–permissive (minus Ca2+). Critically, all four
bacteria retained the ability to synthesize and secrete a YopN-
TyeA chimeric protein of ~42 kDa (Figure 10). However, it was
evident that bacteria producing YopNΔ278F or YopNΔ279W had lost
the capacity to maintain control of Ysc-Yop T3S, since product
was constitutively made and secreted regardless of Ca2+
concentration (Figure 10). Hence, the codons 278 and 279 are
relevant for YopN activity, but on their own are not solely
responsible for the frame-shifting event. This must mean that
the frame-shifting mechanism is more complex than previously
appreciated, requiring more than just a ribosomal pausing site.
In fact, probably no single feature is alone responsible, with
additional architectural features neighbouring the site bound to
make necessary contributions.
Discussion
The InvE family of T3S regulators primarily exist as singular
proteins [33]. However, a subset of these present in the Ysc-
Yop evolutionary clade of T3SSs exist as two separate
polypeptides i.e. in the form of YopN- and TyeA-like proteins
[2]. This study revealed that Y. pseudotuberculosis YopN and
TyeA can be synthesised as a singular YopN-TyeA stable
polypeptide, corroborating existence of a naturally occurring
YopN-TyeA hybrid first observed in Y. pestis [39]. In cis
mutants of Y. pseudotuberculosis engineered to synthesize
solely the YopN-TyeA hybrid proved a useful tool to thoroughly
probe function. At least in vitro, YopN-TyeA hybrids are
efficiently secreted and can themselves control the low Ca2+-
dependent T3S of other Yops. However, shortcomings of this
secretion control first revealed during bacteria-target eukaryotic
cell contact, impact negatively on their ability to survive during
in vivo co-infection of mice. Hence, while YopN-TyeA fusions
are functional in calcium regulation of Yops secretion, these
alleles are not as good as wild type YopN and TyeA produced
as discrete polypeptides. As yet, we have no molecular
comprehension for why some type III secretion systems prefer
two polypeptides and others prefer one. More apparent was
that our standard in vitro assays routinely used to assess
defects in Yop regulatory control can lack the sensitivity to
detect subtle abnormalities. It follows though that any such
abnormalities identifiable in vitro, no matter how subtle, are
most likely meaningful in the context of bacterial colonization
and survival in vivo during an animal model infection.
Although many frame-shifting events are errors in mRNA
translation processing that result in mRNA decay and partly
completed non-functional products, programmed frame-shifting
can be an important translational control mechanism for
regulating the production or diversity of protein entities [56-60].
Figure 10.  Analysis of Yop synthesis and secretion in YopN mutants manipulated at codons 278 or 279.  Overnight cultures
of Y. pseudotuberculosis were sub-cultured into BHI medium in the presence (+) or absence (-) of calcium ions at 26°C for 1 hour
and at 37°C for 3 hours. Protein in the total bacterial suspension (Synthesis) and free in the cleared culture supernatant (Secretion)
were collected, fractionated by 12% acrylamide SDS-PAGE, wet-blotted onto PDVF membrane and then detected using rabbit
polyclonal anti-YopN. The arrow (→) is pointing toward a non-specific protein band recognized by the anti-YopN antiserum. The
single asterisk (*) highlights the single YopN polypeptide, while the double asterisk (**) indicates the larger YopN-TyeA hybrid
protein. Lanes: Parent (YopNYps), YPIII/pIB102; YopNYps→Yen, YPIII/pIB8214; YopNF278F, YPIII/pIB8215; YopNW279F, YPIII/pIB8216;
YopNΔ278F, YPIII/pIB8217; YopNΔ279W, YPIII/pIB8218. Approximate molecular mass values shown in parentheses were deduced from
primary amino acid sequences.
doi: 10.1371/journal.pone.0077767.g010
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For good reasons, natural YopN-TyeA hybrid production in Y.
pestis was thought to involve a +1 translational frame-shift
brought about by a UUU-UGG ribosomal pausing site at codon
positions 278 and 279 of yopN mRNA [39]. This raised the
possibility of this being a genuine ‘programmed’ frame-shift that
had evolved to modulate YopN-TyeA hybrid levels for a
physiological purpose. In reality however, disruption of this
putative UUU-UGG ribosomal pausing site in yopN of Y.
pseudotuberculosis had no detrimental impact on YopN-TyeA
hybrid formation (see Figure 10). This observation could mean
that this sequence is not the actual ribosomal pausing site.
However, this could not be confirmed as numerous attempts by
us and others [39] failed to determine directly the amino acid
sequence of purified YopN-TyeA hybrid. On the other hand, it
remains feasible that the frame-shifting mechanism utilizes this
ribosomal pausing site, but requires influence from architectural
features neighbouring the site. As SD sites internal to the open
reading frame influence translational pausing [68-70], it is
conceivable that composition and location of the putative SD
sequence of tyeA relative to the upstream pausing site and the
downstream tyeA initiation codon could affect the extent of
YopN-TyeA formation. In addition, frame-shifting can be heavily
influenced by the mRNA secondary structure downstream of
the pausing site [71,72], and can also be controlled by codon
usage and the relative abundance of a given tRNA [73,74].
Thus, a number of epigenetic features have potential to
influence frame-shifting events that lead to YopN-TyeA
formation.
Epigenetic regulatory elements aside, it is also established
that polyamines can enhance +1 frame-shifting [75].
Polyamines are small polycationic molecules ubiquitous in
almost all life-forms [76,77]. They have a natural affinity for
binding to RNA, which affords them the opportunity to alter
protein synthesis in ways that influence multiple cellular
functions [76,77]. The prospect that polyamines could influence
the frame-shifting event leading to YopN-TyeA hybrid
production is tantalising given how they are already linked to
controlling T3SS activity in some bacteria [78,79]. Thus, it is
apparent that the frame-shifting event leading to YopN-TyeA
formation is probably multifaceted; dissecting this mechanism
will need to address numerous possible influences.
Engineering a +1 frameshift after codon 278 or codon 287
had the purpose of coercing the production of a YopN-TyeA
hybrid. Remarkably, these bulkier hybrids are accumulated to
higher levels than the single YopN product, are efficiently
secreted and, to varying degrees, also support the T3S control
of other Yops. In our minds, the secretion of YopN-TyeA
underlines the tolerance that T3SSs display for the secretion of
diverse substrates. It seems that the YopN-TyeA polypeptide
still boasts a recognisable N-terminal secretion signal [80], can
still be piloted for secretion by cognate heterodimeric T3S
chaperone composed of YscB and SycN [36,81], and can still
unfold itself in a manner that must ensure both controlled and
efficient secretion via the Ysc-Yop T3SS [82], and only when
the bacteria senses the appropriate environmental signals.
In reality, functional hybrids contain a C-terminal YopN
sequence between residues 278 to 286 that barely resembles
native YopN, and the residues beyond 287 no longer exist as
they are replaced by the TyeA N-terminus (see Figure 2). In
particular, a +1 frame-shift after 278 appeared to produce a
more defective hybrid – as evidenced by decreased polarized
secretion following cell contact and virulence attenuation – then
when introducing a +1 frame-shift after codon 287. Consistent
with this, the former hybrids contain several more amino acid
modifications in the YopN C-terminal sequence. We speculate
that these extra changes might be the reason for a more
defective hybrid entity. This could be either as a direct
consequence of reducing activity of the YopN module or
through generating a less flexible TyeA tail module. Since
specific deletion of either codon 278 or 279 produced YopN
variants with inferior control of Yop synthesis and secretion
(see Figure 10), this suggests that the native YopN C-terminal
segment has a key role in mediating T3S control. This will be
addressed in our future work.
Independent methods have also indicated that at least a
portion of YopN can be translocated into eukaryotic cells, in a
process that is negatively influenced by the presence of
functional TyeA [38,66]. With no known enzymatic activity or
intracellular molecular target, the relevance of translocated
YopN remains obscure. This study did not attempt to
investigate if any of the YopN-TyeA hybrids are translocated
into HeLa cell monolayers. If a legitimate role for YopN
translocation is identified, the YopN-TyeA hybrids could be
used to investigate by what mechanism the presence of a C-
terminal TyeA appendage quenches this YopN activity.
As already hinted above, it is also possible that TyeA
function within these engineered hybrids is affected. For
example, hybrid secretion places this TyeA component outside
of the cell, effectively depleting its cytoplasmic pools. Past
conjecture has surrounded the secretory status of native TyeA
[34,61,62]. However, the current paradigm for Yop secretion
control places TyeA in the cytoplasm, functioning as an
intracellular anchor facilitating the plugging of the secretory
channel by YopN [41]. It is also probable that TyeA fused to the
C-terminus of YopN becomes less supple, losing the required
flexibility to perform its YopN anchoring role. Structural
flexibility of TyeA may be needed for other protein-protein
interactions. Aside from YopN, TyeA has been shown to
interact with YopD [34,61] and more recently YscG and a
hypothetical protein annotated as YPCD1.16C in Y. pestis
(pYV0009 in Y. pseudotuberculosis IP32953) [83]. However,
the significance of these reported interactions is unclear; it is
not known whether any of them assist TyeA in anchoring the
YopN plug to control Yops secretion. Interestingly, the well-
studied YopD protein has a role both inside and outside of the
bacteria [55,84], theoretically making it available to either non-
secreted or secreted TyeA. At any rate, altering the context of
TyeA function beyond YopN may explain the reduced fitness in
mice (see Figure 8 and Table S2) and the sluggish secretion
control (see Figures 6 and 9) of bacteria producing the 278(F
+1) series of hybrids. Our YopN-TyeA hybrids, or variants
thereof, where cytoplasmic TyeA depletion is forced, could
open up unexplored avenues to study the mechanism of TyeA-
dependent anchoring of YopN in addition to revealing the
biological consequences of these other TyeA-dependent
protein-protein interactions.
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Another point is that free TyeA produced as an independent
polypeptide may affect YopN-TyeA hybrid function. For
example, this native TyeA could engage with the YopN
component of the hybrid, potentially contributing to the small
phenotypic differences we have observed in this study. For this
reason we generated two extra hybrids (i.e. the SD-minus
YopN 278(F+1), SDTyeA and YopN 287(F+1), SDTyeA mutants) having
a ‘scrambled’ sequence aimed at disrupting a probable SD site
of tyeA to limit its production. However, western blotting
confirmed that all four hybrids (i.e. regardless of the SD
sequence being intact or disrupted) produced very little to no
detectable free TyeA. First of all, these data cannot
substantiate whether the nucleotides ‘AGAGGG’ (see Figure 2)
do actually represent a bona fide SD of tyeA. In addition, we
found no correlation between native free TyeA production and
the modest phenotypic defects displayed by the YopN-TyeA
chimeras. Therefore, it seems unlikely that a free native TyeA
bias (i.e. in the SD+ mutants of YopN278(F+1), TyeA and YopN287(F
+1), TyeA) can account for the defects in functionality of the
hybrids.
Analysis of the InvE family of proteins is adding credence to
the concept of a secretion hierarchy among the middle
translocator substrates and the late effector secretion
substrates [19,25-31]. This is attractive because it fits nicely
with the original tenet that the translocon pore should form in
the host cell plasma membrane before substrates destined for
translocation through this pore are actually secreted. As
described in a recent review [41], there is some evidence that
Yersinia preferentially secretes YopB and YopD translocator
substrates in Ca2+ rich media that otherwise prevents Yop
effector secretion. In these situations (i.e. prior to cell contact or
in the presence of elevated calcium), it is the YopN/SycN/YscB/
TyeA complex that inhibits effector secretion in order to
prioritise translocator secretion [38,66]. This cannot be true of
all situations however, since unstimulated Y.
pseudotuberculosis contains on their surface both Yop
translocators and Yop effectors in equal measure that proceed
to form translocation-competent Yop complexes [63].
Moreover, our western blotting experiments probing for levels
of both the YopD translocator and the YopE effector in defined
yopN-tyeA mutants did not reveal any preferential secretion of
YopD in Ca2+ replete conditions in vitro (e.g. see Figure 5).
Hence, if hierarchical secretion does exist in Y.
pseudotuberculosis, YopN and TyeA apparently do not
orchestrate it. Interestingly, it appeared that basal levels of
YopD are always subtly higher than YopE both in vitro (see
Figure 9) and during cell contact (see Figure 6). This is
reminiscent of recent studies purporting to a hierarchical Yops
expression profile instigated through the translation-inhibitory
effects of YopD/LcrH complexes differentially bound to the
various 5´-untranslated regions of yop mRNAs [84,85].
Arguably therefore, any preference for prioritising translocator
secretion may have its genesis in regulating cytoplasmic pools
of pre-made Yops.
In summary, this study was unable to show any direct
support for YopN and TyeA in orchestrating hierarchical
secretion among the Yop translocator and effector substrates.
However, it was clear that no matter how subtle the regulatory
defects were in controlling Yop synthesis and secretion in vitro,
they had a direct impact on the in vivo fitness of Yersinia
bacteria. Our outcomes also lead us to posit that work aimed at
further unravelling the specific mechanisms of feedback
inhibition and post-transcriptional control of yops expression
through YopD function could have fertile consequences for
understanding how Yersinia might consider prioritising different
Yop substrates for secretion.
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Figure S1.  Analysis of free TyeA synthesis and secretion
in synthetic YopN-TyeA chimeric mutants. Overnight
cultures of Y. pseudotuberculosis were sub-cultured into BHI
medium in the absence of calcium ions at 26°C for 1 hour and
at 37°C for 3 hours. At the time of temperature up-shift, 0.4 mM
IPTG was added to all cultures. Protein in the total bacterial
suspension (Synthesis) and free in the cleared culture
supernatant (Secretion) were collected, fractionated by 15%
acrylamide SDS-PAGE, wet-blotted onto PDVF membrane and
then detected using rabbit polyclonal anti-TyeA antibodies. The
arrow (→) point towards a non-specific protein band
recognized by the anti-TyeA antiserum. The single asterisk (*)
highlights the larger YopN-TyeA hybrid protein. Lanes are Y.
pseudotuberculosis ΔyopN, tyeA (YPIII/pIB8201a) also
containing pYopN, TyeA+ (pAA304), empty vector (pMMB208),
pYopN278(F+1), TyeA+ (pAA306), pYopN278(F+1), SD, TyeA+
(pAA307), pYopN287(F+1), TyeA+ (pAA308), or pYopN287(F+1), SD,
TyeA+ (pAA309). Approximate molecular mass values shown in
parentheses were deduced from primary amino acid
sequences.
(TIF)
Figure S2.  YopN-TyeA hybrid-producing bacteria spawn
external YscF multimers. Yersinia strains were grown in non
permissive T3S media (plus Ca2+). Where indicated (+), the
membrane-impermeable chemical cross-linker BS3 was added
to the bacteria. After being quenched with Tris-HCl, bacteria
pellets were solubilized in sample buffer and then protein
fractionated by 12% acrylamide SDS-PAGE. After wet-transfer
to PVDF, YscF was detected with immune-absorbed
monospecific anti-YscF antiserum. Non-cross-linked
monomeric YscF was observed in all lanes except the ΔyscF
null mutant control. Cell-surface YscF multimers were observed
in all lanes except for the ΔyscF null mutant control as well as
the YscF+, but T3SS-defective, ΔyscU, lcrQ null mutant control.
The predicted molecular mass of monomeric YscF is given in
parenthesis, while approximate sizes of protein molecular
weight standards are given to the right. Strains: Parent
(YopNYps), YPIII/pIB102; ΔyopN null mutant, YPIII/pIB82; ΔtyeA
null mutant, YPIII/pIB801a; ΔyopN, tyeA double mutant, YPIII/
pIB8201a; YopN 278(F+1)TyeA, YPIII/pIB8205; YopN 278(F+1),
SDTyeA, YPIII/pIB8206; YopN 287(F+1)TyeA, YPIII/pIB8210; YopN
287(F+1), SDTyeA, YPIII/pIB8211; ΔyscF null mutant, YPIII/pIB202;
ΔyscU, lcrQ double mutant, YPIII/pIB75-26.
(TIF)
Functional YopN-TyeA Chimeras
PLOS ONE | www.plosone.org 20 October 2013 | Volume 8 | Issue 10 | e77767
Figure S3.  Low calcium response growth phenotypes of Y.
pseudotuberculosis producing YopN-TyeA hybrids.
Bacteria were grown at 37°C in TMH medium supplemented
with 2.5 mM CaCl2 (plus Ca2+; A) or non-supplemented (minus
Ca2+; B). Two different growth phenotypes were detected: TS –
bacteria are sensitive to elevated temperature regardless of the
presence or absence of calcium (ΔyopN and/or ΔtyeA null
mutants) and, CD – calcium dependent growth (all remaining
strains). Strains: Parent (YopNYps), YPIII/pIB102; ΔyopN null
mutant, YPIII/pIB82; ΔtyeA null mutant, YPIII/pIB801a; ΔyopN,
tyeA double mutant, YPIII/pIB8201a; YopN 278(F+1)TyeA, YPIII/
pIB8205; YopN 278(F+1), SDTyeA, YPIII/pIB8206; YopN 287(F
+1)TyeA, YPIII/pIB8210; YopN 287(F+1), SDTyeA, YPIII/pIB8211.
(TIF)
Table S1.  Oligonucleotides used in this study.
(PDF)
Table S2.  Competitive index for mice colonization.
(PDF)
Acknowledgements
This work was performed within the virtual framework of the
Umeå Center for Microbial Research Linnaeus Program and
Molecular Infection Medicine Sweden. We express gratitude to
Hans Wolf-Watz (Umeå University, Umeå, Sweden) for the
gifts of antiserum specific to DnaK and various Ysc/Yop
antigens and Gregory Plano (University of Miami, FL, USA) for
the gift of anti-TyeA antiserum.
Author Contributions
Conceived and designed the experiments: AAAA TRDC UA ÅF
MSF. Performed the experiments: AAAA TRDC SIF ÅF MSF.
Analyzed the data: AAAA ÅF MSF. Contributed reagents/
materials/analysis tools: UA ÅF. Wrote the manuscript: AAAA
MSF.
References
1. Büttner D (2012) Protein export according to schedule: architecture,
assembly, and regulation of type III secretion systems from plant- and
animal-pathogenic bacteria. Microbiol Mol Biol Rev 76: 262-310. doi:
10.1128/MMBR.05017-11. PubMed: 22688814.
2. Troisfontaines P, Cornelis GR (2005) Type III secretion: more systems
than you think. Physiology (Bethesda) 20: 326-339. doi:10.1152/
physiol.00011.2005. PubMed: 16174872.
3. Edgren T, Forsberg A, Rosqvist R, Wolf-Watz H (2012) Type III
secretion in Yersinia: injectisome or not? PLOS Pathog 8: e1002669.
4. Francis MS (2010) Type III secretion chaperones: a molecular toolkit
for all occasions. In: P DuranteL Colucci. Handbook of molecular
chaperones: roles, structures and mechanisms. Hauppauge, NY: Nova
Science Publishers, Inc.. pp. 79-147.
5. Galán JE (2007) SnapShot: effector proteins of type III secretion
systems. Cell 130: 192. PubMed: 17632065.
6. Brutinel ED, Yahr TL (2008) Control of gene expression by type III
secretory activity. Curr Opin Microbiol 11: 128-133. doi:10.1016/j.mib.
2008.02.010. PubMed: 18396449.
7. Osborne SE, Coombes BK (2011) Expression and secretion hierarchy
in the nonflagellar type III secretion system. Future Microbiol 6:
193-202. doi:10.2217/fmb.10.172. PubMed: 21366419.
8. Deane JE, Abrusci P, Johnson S, Lea SM (2010) Timing is everything:
the regulation of type III secretion. Cell Mol Life Sci 67: 1065-1075. doi:
10.1007/s00018-009-0230-0. PubMed: 20043184.
9. Flores-Kim J, Darwin AJ (2012) Links between type III secretion and
extracytoplasmic stress responses in Yersinia. Front Cell Infect
Microbiol 2: 125. PubMed: 23087910.
10. Francis MS (2011) Secretion systems and metabolism in the
pathogenic Yersiniae. In: SP Kidd. Stress response in pathogenic
bacteria. Wallingford, Oxfordshire, UK: CABI Publishing. pp. 185-220.
11. Magdalena J, Hachani A, Chamekh M, Jouihri N, Gounon P et al.
(2002) Spa32 regulates a switch in substrate specificity of the type III
secreton of Shigella flexneri from needle components to Ipa proteins. J
Bacteriol 184: 3433-3441. doi:10.1128/JB.184.13.3433-3441.2002.
PubMed: 12057936.
12. Tamano K, Katayama E, Toyotome T, Sasakawa C (2002) Shigella
Spa32 is an essential secretory protein for functional type III secretion
machinery and uniformity of its needle length. J Bacteriol 184:
1244-1252. doi:10.1128/JB.184.5.1244-1252.2002. PubMed:
11844752.
13. Edqvist PJ, Olsson J, Lavander M, Sundberg L, Forsberg Å et al.
(2003) YscP and YscU regulate substrate specificity of the Yersinia
type III secretion system. J Bacteriol 185: 2259-2266. doi:10.1128/JB.
185.7.2259-2266.2003. PubMed: 12644497.
14. Agrain C, Callebaut I, Journet L, Sorg I, Paroz C et al. (2005)
Characterization of a Type III secretion substrate specificity switch
(T3S4) domain in YscP from Yersinia enterocolitica. Mol Microbiol 56:
54-67. doi:10.1111/j.1365-2958.2005.04534.x. PubMed: 15773978.
15. Marlovits TC, Kubori T, Lara-Tejero M, Thomas D, Unger VM et al.
(2006) Assembly of the inner rod determines needle length in the type
III secretion injectisome. Nature 441: 637-640. doi:10.1038/
nature04822. PubMed: 16738660.
16. Lorenz C, Schulz S, Wolsch T, Rossier O, Bonas U et al. (2008) HpaC
controls substrate specificity of the Xanthomonas type III secretion
system. PLOS Pathog 4: e1000094. PubMed: 18584024.
17. Wood SE, Jin J, Lloyd SA (2008) YscP and YscU switch the substrate
specificity of the Yersinia type III secretion system by regulating export
of the inner rod protein YscI. J Bacteriol 190: 4252-4262. doi:
10.1128/JB.00328-08. PubMed: 18424518.
18. Björnfot AC, Lavander M, Forsberg A, Wolf-Watz H (2009)
Autoproteolysis of YscU of Yersinia pseudotuberculosis is important for
regulation of expression and secretion of Yop proteins. J Bacteriol 191:
4259-4267. doi:10.1128/JB.01730-08. PubMed: 19395493.
19. Cherradi Y, Schiavolin L, Moussa S, Meghraoui A, Meksem A et al.
(2013) Interplay between predicted inner-rod and gatekeeper in
controlling substrate specificity of the type III secretion system. Mol
Microbiol 87: 1183-1199. doi:10.1111/mmi.12158. PubMed: 23336839.
20. Sal-Man N, Deng W, Finlay BB (2012) EscI: a crucial component of the
type III secretion system forms the inner rod structure in
enteropathogenic Escherichia coli. Biochem J 442: 119-125. doi:
10.1042/BJ20111620. PubMed: 22087554.
21. Monjarás Feria J, García-Gómez E, Espinosa N, Minamino T, Namba K
et al. (2012) Role of EscP (Orf16) in injectisome biogenesis and
regulation of type III protein secretion in enteropathogenic Escherichia
coli. J Bacteriol 194: 6029-6045. doi:10.1128/JB.01215-12. PubMed:
22923600.
22. Thomassin JL, He X, Thomas NA (2011) Role of EscU auto-cleavage
in promoting type III effector translocation into host cells by
enteropathogenic Escherichia coli. BMC Microbiol 11: 205. doi:
10.1186/1471-2180-11-205. PubMed: 21933418.
23. Zarivach R, Deng W, Vuckovic M, Felise HB, Nguyen HV et al. (2008)
Structural analysis of the essential self-cleaving type III secretion
proteins EscU and SpaS. Nature 453: 124-127. doi:10.1038/
nature06832. PubMed: 18451864.
24. Frost S, Ho O, Login FH, Weise CF, Wolf-Watz H et al. (2012)
Autoproteolysis and intramolecular dissociation of Yersinia YscU
precedes secretion of its C-terminal polypeptide YscU. PLOS ONE
7(11):e49349.
25. Kubori T, Galán JE (2002) Salmonella type III secretion-associated
protein InvE controls translocation of effector proteins into host cells. J
Bacteriol 184: 4699-4708. doi:10.1128/JB.184.17.4699-4708.2002.
PubMed: 12169593.
26. Kim JS, Jang JI, Eom JS, Oh CH, Kim HG et al. (2013) Molecular
characterization of the InvE regulator in the secretion of type III
secretion translocases in Salmonella enterica serovar Typhimurium.
Microbiology 159: 446-461. doi:10.1099/mic.0.061689-0. PubMed:
23288540.
Functional YopN-TyeA Chimeras
PLOS ONE | www.plosone.org 21 October 2013 | Volume 8 | Issue 10 | e77767
27. Deng W, Li Y, Hardwidge PR, Frey EA, Pfuetzner RA et al. (2005)
Regulation of type III secretion hierarchy of translocators and effectors
in attaching and effacing bacterial pathogens. Infect Immun 73:
2135-2146. doi:10.1128/IAI.73.4.2135-2146.2005. PubMed: 15784556.
28. O’Connell CB, Creasey EA, Knutton S, Elliott S, Crowther LJ et al.
(2004) SepL, a protein required for enteropathogenic Escherichia coli
type III translocation, interacts with secretion component SepD. Mol
Microbiol 52: 1613-1625. doi:10.1111/j.1365-2958.2004.04101.x.
PubMed: 15186412.
29. Wang D, Roe AJ, McAteer S, Shipston MJ, Gally DL (2008) Hierarchal
type III secretion of translocators and effectors from Escherichia coli
O157:H7 requires the carboxy terminus of SepL that binds to Tir. Mol
Microbiol 69: 1499-1512. doi:10.1111/j.1365-2958.2008.06377.x.
PubMed: 18673458.
30. Botteaux A, Sory MP, Biskri L, Parsot C, Allaoui A (2009) MxiC is
secreted by and controls the substrate specificity of the Shigella flexneri
type III secretion apparatus. Mol Microbiol 71: 449-460. doi:10.1111/j.
1365-2958.2008.06537.x. PubMed: 19017268.
31. Martinez-Argudo I, Blocker AJ (2010) The Shigella T3SS needle
transmits a signal for MxiC release, which controls secretion of
effectors. Mol Microbiol 78: 1365-1378. PubMed: 21143311.
32. Marchler-Bauer A, Zheng C, Chitsaz F, Derbyshire MK, Geer LY et al.
(2013) CDD: conserved domains and protein three-dimensional
structure. Nucleic Acids Res 41: D348-D352. doi:10.1093/nar/gks1243.
PubMed: 23197659.
33. Pallen MJ, Beatson SA, Bailey CM (2005) Bioinformatics analysis of
the locus for enterocyte effacement provides novel insights into type-III
secretion. BMC Microbiol 5: 9. doi:10.1186/1471-2180-5-9. PubMed:
15757514.
34. Cheng LW, Schneewind O (2000) Yersinia enterocolitica TyeA, an
intracellular regulator of the type III machinery, is required for specific
targeting of YopE, YopH, YopM, and YopN into the cytosol of
eukaryotic cells. J Bacteriol 182: 3183-3190.
35. Ferracci F, Schubot FD, Waugh DS, Plano GV (2005) Selection and
characterization of Yersinia pestis YopN mutants that constitutively
block Yop secretion. Mol Microbiol 57: 970-987. doi:10.1111/j.
1365-2958.2005.04738.x. PubMed: 16091038.
36. Joseph SS, Plano GV (2013) The SycN/YscB chaperone-binding
domain of YopN is required for the calcium-dependent regulation of
Yop secretion by Yersinia pestis. Front Cell Infect Microbiol 3: 1.
PubMed: 23355975.
37. Forsberg Å, Viitanen AM, Skurnik M, Wolf-Watz H (1991) The surface-
located YopN protein is involved in calcium signal transduction in
Yersinia pseudotuberculosis. Mol Microbiol 5: 977-986. doi:10.1111/j.
1365-2958.1991.tb00773.x. PubMed: 1857212.
38. Cheng LW, Kay O, Schneewind O (2001) Regulated secretion of YopN
by the type III machinery of Yersinia enterocolitica. J Bacteriol 183:
5293-5301. doi:10.1128/JB.183.18.5293-5301.2001. PubMed:
11514512.
39. Ferracci F, Day JB, Ezelle HJ, Plano GV (2004) Expression of a
functional secreted YopN-TyeA hybrid protein in Yersinia pestis is the
result of a +1 translational frameshift event. J Bacteriol 186: 5160-5166.
doi:10.1128/JB.186.15.5160-5166.2004. PubMed: 15262954.
40. Lee VT, Mazmanian SK, Schneewind O (2001) A program of Yersinia
enterocolitica type III secretion reactions is activated by specific
signals. J Bacteriol 183: 4970-4978. doi:10.1128/JB.
183.17.4970-4978.2001. PubMed: 11489848.
41. Dewoody RS, Merritt PM, Marketon MM (2013) Regulation of the
Yersinia type III secretion system: traffic control. Front Cell Infect
Microbiol 3: 4. PubMed: 23390616.
42. Pettersson J, Nordfelth R, Dubinina E, Bergman T, Gustafsson M et al.
(1996) Modulation of virulence factor expression by pathogen target
cell contact. Science 273: 1231-1233. doi:10.1126/science.
273.5279.1231. PubMed: 8703058.
43. Rosqvist R, Magnusson KE, Wolf-Watz H (1994) Target cell contact
triggers expression and polarized transfer of Yersinia YopE cytotoxin
into mammalian cells. EMBO J 13: 964-972. PubMed: 8112310.
44. Schiano CA, Lathem WW (2012) Post-transcriptional regulation of gene
expression in Yersinia species. Front Cell Infect Microbiol 2: 129.
PubMed: 23162797.
45. Amer AA, Åhlund MK, Bröms JE, Forsberg A, Francis MS (2011)
Impact of the N-terminal secretor domain on YopD translocator function
in Yersinia pseudotuberculosis type III secretion. J Bacteriol 193:
6683-6700. doi:10.1128/JB.00210-11. PubMed: 21965570.
46. Milton DL, O’Toole R, Horstedt P, Wolf-Watz H (1996) Flagellin A is
essential for the virulence of Vibrio anguillarum. J Bacteriol 178:
1310-1319. PubMed: 8631707.
47. Bölin I, Wolf-Watz H (1984) Molecular cloning of the temperature-
inducible outer membrane protein 1 of Yersinia pseudotuberculosis.
Infect Immun 43: 72-78. PubMed: 6317574.
48. Feldman MF, Müller S, Wüest E, Cornelis GR (2002) SycE allows
secretion of YopE-DHFR hybrids by the Yersinia enterocolitica type III
Ysc system. Mol Microbiol 46: 1183-1197. doi:10.1046/j.
1365-2958.2002.03241.x. PubMed: 12421321.
49. Morales VM, Bäckman A, Bagdasarian M (1991) A series of wide-host-
range low-copy-number vectors that allow direct screening for
recombinants. Gene 97: 39-47. doi:10.1016/0378-1119(91)90007-X.
PubMed: 1847347.
50. Straley SC, Bowmer WS (1986) Virulence genes regulated at the
transcriptional level by Ca2+ in Yersinia pestis include structural genes
for outer membrane proteins. Infect Immun 51: 445-454. PubMed:
3002984.
51. Rosqvist R, Forsberg Å, Wolf-Watz H (1991) Intracellular targeting of
the Yersinia YopE cytotoxin in mammalian cells induces actin
microfilament disruption. Infect Immun 59: 4562-4569. PubMed:
1937815.
52. Francis MS, Wolf-Watz H (1998) YopD of Yersinia pseudotuberculosis
is translocated into the cytosol of HeLa epithelial cells: evidence of a
structural domain necessary for translocation. Mol Microbiol 29:
799-813. doi:10.1046/j.1365-2958.1998.00973.x. PubMed: 9723919.
53. Bartra S, Cherepanov P, Forsberg A, Schesser K (2001) The Yersinia
YopE and YopH type III effector proteins enhance bacterial proliferation
following contact with eukaryotic cells. BMC Microbiol 1: 22. doi:
10.1186/1471-2180-1-22. PubMed: 11696238.
54. Costa TR, Amer AA, Fällman M, Fahlgren A, Francis MS (2012) Coiled-
coils in the YopD translocator family: A predicted structure unique to
the YopD N-terminus contributes to full virulence of Yersinia
pseudotuberculosis. Infect Genet Evol 12: 1729-1742. doi:10.1016/
j.meegid.2012.07.016. PubMed: 22910185.
55. Costa TR, Amer AA, Farag SI, Wolf-Watz H, Fällman M et al. (2013)
Type III secretion translocon assemblies that attenuate Yersinia
virulence. Cell Microbiol 15: 1088-1110. doi:10.1111/cmi.12100.
PubMed: 23279117.
56. Dinman JD (2012) Mechanisms and implications of programmed
translational frameshifting. Wiley Interdiscip Rev RNA 3: 661-673. doi:
10.1002/wrna.1126. PubMed: 22715123.
57. Buchan JR, Stansfield I (2007) Halting a cellular production line:
responses to ribosomal pausing during translation. Biol Cell 99:
475-487. doi:10.1042/BC20070037. PubMed: 17696878.
58. Baranov PV, Gesteland RF, Atkins JF (2002) Recoding: translational
bifurcations in gene expression. Gene 286: 187-201. doi:10.1016/
S0378-1119(02)00423-7. PubMed: 11943474.
59. Namy O, Rousset JP, Napthine S, Brierley I (2004) Reprogrammed
genetic decoding in cellular gene expression. Mol Cell 13: 157-168. doi:
10.1016/S1097-2765(04)00031-0. PubMed: 14759362.
60. Farabaugh PJ (1996) Programmed translational frameshifting. Annu
Rev Genet 30: 507-528. doi:10.1146/annurev.genet.30.1.507. PubMed:
8982463.
61. Iriarte M, Sory MP, Boland A, Boyd AP, Mills SD et al. (1998) TyeA, a
protein involved in control of Yop release and in translocation of
Yersinia Yop effectors. EMBO J 17: 1907-1918. doi:10.1093/emboj/
17.7.1907. PubMed: 9524114.
62. Sundberg L, Forsberg A (2003) TyeA of Yersinia pseudotuberculosis is
involved in regulation of Yop expression and is required for polarized
translocation of Yop effectors. Cell Microbiol 5: 187-202. doi:10.1046/j.
1462-5822.2003.00267.x. PubMed: 12614462.
63. Akopyan K, Edgren T, Wang-Edgren H, Rosqvist R, Fahlgren A et al.
(2011) Translocation of surface-localized effectors in type III secretion.
Proc Natl Acad Sci U S A 108: 1639-1644. doi:10.1073/pnas.
1013888108. PubMed: 21220342.
64. Persson C, Nordfelth R, Holmström A, Håkansson S, Rosqvist R et al.
(1995) Cell-surface-bound Yersinia translocate the protein tyrosine
phosphatase YopH by a polarized mechanism into the target cell. Mol
Microbiol 18: 135-150. doi:10.1111/j.1365-2958.1995.mmi_18010135.x.
PubMed: 8596454.
65. Lee VT, Anderson DM, Schneewind O (1998) Targeting of Yersinia Yop
proteins into the cytosol of HeLa cells: one-step translocation of YopE
across bacterial and eukaryotic membranes is dependent on SycE
chaperone. Mol Microbiol 28: 593-601. doi:10.1046/j.
1365-2958.1998.00822.x. PubMed: 9632261.
66. Day JB, Ferracci F, Plano GV (2003) Translocation of YopE and YopN
into eukaryotic cells by Yersinia pestis yopN, tyeA, sycN, yscB and lcrG
deletion mutants measured using a phosphorylatable peptide tag and
phosphospecific antibodies. Mol Microbiol 47: 807-823. doi:10.1046/j.
1365-2958.2003.03343.x. PubMed: 12535078.
Functional YopN-TyeA Chimeras
PLOS ONE | www.plosone.org 22 October 2013 | Volume 8 | Issue 10 | e77767
67. Viboud GI, Bliska JB (2005) Yersinia outer proteins: role in modulation
of host cell signaling responses and pathogenesis. Annu Rev Microbiol
59: 69-89. doi:10.1146/annurev.micro.59.030804.121320. PubMed:
15847602.
68. Li GW, Oh E, Weissman JS (2012) The anti-Shine-Dalgarno sequence
drives translational pausing and codon choice in bacteria. Nature 484:
538-541. doi:10.1038/nature10965. PubMed: 22456704.
69. Chen H, Bjerknes M, Kumar R, Jay E (1994) Determination of the
optimal aligned spacing between the Shine-Dalgarno sequence and the
translation initiation codon of Escherichia coli mRNAs. Nucleic Acids
Res 22: 4953-4957. doi:10.1093/nar/22.23.4953. PubMed: 7528374.
70. Weiss RB, Dunn DM, Dahlberg AE, Atkins JF, Gesteland RF (1988)
Reading frame switch caused by base-pair formation between the 3'
end of 16S rRNA and the mRNA during elongation of protein synthesis
in Escherichia coli. EMBO J 7: 1503-1507. PubMed: 2457498.
71. Hansen TM, Reihani SN, Oddershede LB, Sørensen MA (2007)
Correlation between mechanical strength of messenger RNA
pseudoknots and ribosomal frameshifting. Proc Natl Acad Sci U S A
104: 5830-5835. doi:10.1073/pnas.0608668104. PubMed: 17389398.
72. Kontos H, Napthine S, Brierley I (2001) Ribosomal pausing at a
frameshifter RNA pseudoknot is sensitive to reading phase but shows
little correlation with frameshift efficiency. Mol Cell Biol 21: 8657-8670.
doi:10.1128/MCB.21.24.8657-8670.2001. PubMed: 11713298.
73. McNulty DE, Claffee BA, Huddleston MJ, Porter ML, Cavnar KM et al.
(2003) Mistranslational errors associated with the rare arginine codon
CGG in Escherichia coli. Protein Expr Purif 27: 365-374. doi:10.1016/
S1046-5928(02)00610-1. PubMed: 12597898.
74. Schwartz R, Curran JF (1997) Analyses of frameshifting at UUU-
pyrimidine sites. Nucleic Acids Res 25: 2005-2011. doi:10.1093/nar/
25.10.2005. PubMed: 9115369.
75. Higashi K, Kashiwagi K, Taniguchi S, Terui Y, Yamamoto K et al.
(2006) Enhancement of +1 frameshift by polyamines during translation
of polypeptide release factor 2 in Escherichia coli. J Biol Chem 281:
9527-9537. PubMed: 16476727.
76. Igarashi K, Kashiwagi K (2010) Modulation of cellular function by
polyamines. Int J Biochem Cell Biol 42: 39-51. doi:10.1016/j.biocel.
2009.07.009. PubMed: 19643201.
77. Shah P, Swiatlo E (2008) A multifaceted role for polyamines in bacterial
pathogens. Mol Microbiol 68: 4-16. doi:10.1111/j.
1365-2958.2008.06126.x. PubMed: 18405343.
78. Jelsbak L, Thomsen LE, Wallrodt I, Jensen PR, Olsen JE (2012)
Polyamines are required for virulence in Salmonella enterica serovar
Typhimurium. PLOS ONE 7: e36149. doi:10.1371/journal.pone.
0036149. PubMed: 22558361.
79. Zhou L, Wang J, Zhang LH (2007) Modulation of bacterial Type III
secretion system by a spermidine transporter dependent signaling
pathway. PLOS ONE 2: e1291. doi:10.1371/journal.pone.0001291.
PubMed: 18074016.
80. Goss JW, Sorg JA, Ramamurthi KS, Ton-That H, Schneewind O (2004)
The secretion signal of YopN, a regulatory protein of the Yersinia
enterocolitica type III secretion pathway. J Bacteriol 186: 6320-6324.
doi:10.1128/JB.186.18.6320-6324.2004. PubMed: 15342604.
81. Day JB, Plano GV (1998) A complex composed of SycN and YscB
functions as a specific chaperone for YopN in Yersinia pestis. Mol
Microbiol 30: 777-788. doi:10.1046/j.1365-2958.1998.01110.x.
PubMed: 10094626.
82. Akeda Y, Galán JE (2005) Chaperone release and unfolding of
substrates in type III secretion. Nature 437: 911-915. doi:10.1038/
nature03992. PubMed: 16208377.
83. Yang H, Tan Y, Zhang T, Tang L, Wang J et al. (2013) Identification of
novel protein-protein interactions of Yersinia pestis type III secretion
system by yeast two hybrid system. PLOS ONE 8: e54121. doi:
10.1371/journal.pone.0054121. PubMed: 23349800.
84. Chen Y, Anderson DM (2011) Expression hierarchy in the Yersinia type
III secretion system established through YopD recognition of RNA. Mol
Microbiol 80: 966-980. doi:10.1111/j.1365-2958.2011.07623.x.
PubMed: 21481017.
85. Anderson DM, Ramamurthi KS, Tam C, Schneewind O (2002) YopD
and LcrH regulate expression of Yersinia enterocolitica YopQ by a
posttranscriptional mechanism and bind to yopQ RNA. J Bacteriol 184:
1287-1295. doi:10.1128/JB.184.5.1287-1295.2002. PubMed:
11844757.
86. Simon R, Priefer U, Pühler A (1983) A broad host range mobilisation
system for in vivo genetic engineering: transposon mutagenesis in
Gram negative bacteria. Nat Biotechnol 1: 784-791. doi:10.1038/
nbt1183-784.
87. Lavander M, Sundberg L, Edqvist PJ, Lloyd SA, Wolf-Watz H et al.
(2002) Proteolytic cleavage of the FlhB homologue YscU of Yersinia
pseudotuberculosis is essential for bacterial survival but not for type III
secretion. J Bacteriol 184: 4500-4509. doi:10.1128/JB.
184.16.4500-4509.2002. PubMed: 12142420.
88. Edqvist PJ, Olsson J, Lavander M, Sundberg L, Forsberg A et al.
(2003) YscP and YscU regulate substrate specificity of the Yersinia
type III secretion system. J Bacteriol 185: 2259-2266. doi:10.1128/JB.
185.7.2259-2266.2003. PubMed: 12644497.
89. Edqvist PJ, Bröms JE, Betts HJ, Forsberg Å, Pallen MJ et al. (2006)
Tetratricopeptide repeats in the type III secretion chaperone, LcrH:
Their role in substrate binding and secretion. Mol Microbiol 59: 31-44.
doi:10.1111/j.1365-2958.2005.04923.x. PubMed: 16359316.
90. Rosqvist R, Forsberg Å, Rimpiläinen M, Bergman T, Wolf-Watz H
(1990) The cytotoxic protein YopE of Yersinia obstructs the primary
host defence. Mol Microbiol 4: 657-667. doi:10.1111/j.
1365-2958.1990.tb00635.x. PubMed: 2191183.
91. Portnoy DA, Moseley SL, Falkow S (1981) Characterization of plasmids
and plasmid-associated determinants of Yersinia enterocolitica
pathogenesis. Infect Immun 31: 775-782. PubMed: 7216474.
92. Schubot FD, Jackson MW, Penrose KJ, Cherry S, Tropea JE et al.
(2005) Three-dimensional structure of a macromolecular assembly that
regulates type III secretion in Yersinia pestis. J Mol Biol 346:
1147-1161. doi:10.1016/j.jmb.2004.12.036. PubMed: 15701523.
Functional YopN-TyeA Chimeras
PLOS ONE | www.plosone.org 23 October 2013 | Volume 8 | Issue 10 | e77767
